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ABSTRACT 
The effective understanding of the biological behavior and prognosis of cancer subtypes is 
becoming very important in-patient administration.  Cancer is a diverse disorder in which a 
significant medical progression and diagnosis for each subtype can be observed and characterized. 
Computer-aided diagnosis for early detection and diagnosis of many kinds of diseases has evolved 
in the last decade. In this research, we address challenges associated with multi-organ disease 
diagnosis and recommend numerous models for enhanced analysis. We concentrate on evaluating 
the Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission 
Tomography (PET) for brain, lung, and breast scans to detect, segment, and classify types of cancer 
from biomedical images.  Moreover, histopathological, and genomic classification of cancer 
prognosis has been considered for multi-organ disease diagnosis and biomarker recommendation. 
We considered multi-modal, multi-class classification during this study. We are proposing 
implementing deep learning technique based on Convolutional Neural Network and Generative 
Adversarial Network. 
In our proposed research we plan to demonstrate ways to increase the performance of the 
disease diagnosis by focusing on a combined diagnosis of histology, image processing, and 
genomics. It has been observed that the combination of medical imaging and gene expression can 
effectively handle the cancer detection situation with higher diagnostic rate rather than considering 
the individual disease diagnosis. This research puts forward a blockchain-based system that 
facilitates interpretations and enhancements pertaining to automated biomedical systems. In this 
scheme, a secured sharing of the biomedical images and gene expression has been established. To 
maintain the secured sharing of the biomedical contents in a distributed system or among the 
hospitals, a blockchain based algorithm is considered that generate a secure sequence to identity a 
hash key. This adaptive feature enables the algorithm to use multiple data types and combines 
various biomedical images and text records. All data related to patients, including identity, 
pathological records are encrypted using a private key cryptography based on blockchain 
architecture to maintain data privacy and secured sharing of the biomedical contents. 
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1    Introduction 
In this chapter, we introduce complete outline to this thesis intended to permit a quick 
assessment of its focus, objectives, contributions, challenges, and structure.  
 Background and Motivations  
Cancer is a heterogeneous cluster of disorders exemplified by unrestrained expansion of 
the cells. Cancers are mostly categorized by the nature of cells or tissue considering their 
origination. Since malignant expansion can arise in almost all locations of the body, around 100 
distinct categories of cancers are obvious. Cancer is an enormously complicated and varied 
disease. Those characteristics, known as traits of cancer, are an integrated set of skills gained 
during tumor genesis. 
In 2012, 14.1 million individuals identified as cancer and 8.2 million people died of that in 
the world. World Health Organization (WHO) estimated that, around 21.7 million people will be 
detected as cancer patient and 13 million individuals will die due to cancer by 2030 [1]. Recently, 
cancer has turn out to be the second prominent source of fatality in the earth. The developing 
countries are facing the large number expansion of cancer due to several factors like heavy 
smoking, poor diet, physical inactivity, and environmental pollutions. Now-a-days, commonly 
identified cancer occurred worldwide are ten different categories. These are lung (13%), breast 
(11.9%), colorectum (9.7%), prostate (7.9%), stomach (6.8%), liver (5.6%), cervix uteri (3.7%), 
and bladder (3.1%) [2]. 
Advances in cancer research have been obvious last a few years, but still remarkable gaps 
can be observed in this field due to the existence of several subtypes of cancer in the world. 
Understanding and knowledge gathering would be essential steps to identify and diagnosis of the 
cancer disease. Researchers now focusing on several distinct subtypes that exist in cancer with 
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distinct roots, various threat aspects, unique genomic alterations, unusual biological activities, and 
dissimilar predictions, and scenarios need to be discovered. Early detection, therapy, and 
supervision of cancers can reduce the risk of the disease [3]. However, failure to detect the cancer 
effectively would occur high chances of mortality. Several key factors that distract the accurate 
identification of the disease is given below: 
 Absence of robust research on precise disease subtypes. 
 Lack of knowledge of genomic probability factors. 
 Scarcity of effective and automated disease detection tools. 
 Inadequate indication-based customized medicine tactics designed to the disease subtypes 
and tumor attributes. 
 Lack of awareness given to research on supportive issues for long term care of patients to 
observe the disease progression 
Machine Learning (ML) has yielded significant improvement in modern years. ML is 
overly used now-a-days in different sectors to achieve incredible performance with high accuracy 
rate in every steps of work. ML models can analyse different types of data like text, image, audio, 
video, etc. to extract information from the data and helps to predict the data sequence if new sets 
of data appear [4]. In this thesis, we aim to use machine learning and deep learning models for 
solving various problems related to biomedical imaging and genome sequencing in terms of giving 
a robust disease diagnostic method.  
In recent years, computer-aided diagnosis (CAD) have been overly used for disease 
diagnosis as it is tedious task for human beings to identify disease instantly from the tons of 
biomedical images and gene expression sequence. Machine learning especially deep learning 
3 
models can play a great role for disease diagnosis by accurately identifying the abnormal regions 
from the medical contents. CAD systems considers those deep learning models reduced the time 
and task of human being with better disease diagnosis. Moreover, vast amount of data can be 
handled smoothly and in a faster way comparing to human being.  
 Aims 
The research work aims to develop more accurate and effective cancer detection model by 
comparing to current disease diagnosis model with the purpose of achieving better performance. 
Therefore, the research approach has followed by involving five main steps  
1. Understanding the existing individual, hybrid disease detection model and their 
applications in different domain  
2. To identify the key issues that can enhance the performance and accuracy of the model  
3. Design and implementation of a new feature extraction technique and incorporate it into 
the model that can be evaluated through performance measurement methods  
4. Investigating a set of deep learning model and consider how the models can be extended 
and which characteristics are necessary to achieve better accuracy  
5. To understand the medical contents collected from internet of medical things (IoMT) 
devices and sharing technique in a distributed environment using blockchain technique. 
Performance analysis of the medical data access, sharing, modification in a centralized or 
distributed system. 
This research aims to address the following questions: 
1. Can deep learning techniques outperform conventional machine learning algorithms in 
detecting and classifying cancer from biomedical images as well as genome sequences? 
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2. How effective the feature extraction techniques in terms of attaining beneficial biomarkers 
from both image and genome perspective? 
3. How can deep learning methods perform finest in terms of limited biomedical data? Which 
deep neural network architecture is appropriate for disease diagnosis? 
4. How to supply security and police investigation for patient medical health records? How 
clinicians/physicians will access the stored data?  
 Objectives  
The objective of this study is- 
1. To develop a computer-aided diagnosis (CAD) system that can process the data effectively 
in terms of identifying abnormality in the medical contents. 
2. To evaluate the performance of the proposed deep learning models with existing real-life 
datasets. 
3. To develop an effective deep learning model for disease diagnosis by considering feature 
extraction technique, segmentation technique, data augmentation technique etc. and 
compare the performance to the state-of-the-art method. 
4. To propose an ensemble classification model for cancer detection. Pre-trained transfer 
learning models can be considered if the dataset is of limited size.  
5. To develop a model with two stage association study of the medical contents from 
biomedical images and genome expression for better identifying the disease.  
6. To protect the personal details of a patient and to produce confidentiality to patient medical 
records victimization using “Blockchain Technology”.  
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 Challenges 
The central focus of this research is to classify and segment biomedical images for 
detecting cancer biomarker from different human organs like lung, breast, eye, etc. Moreover, the 
gene expression analysis using microarray gene expression data of different organs is considered 
for prediction of metastasis. The association study is also a key part for multiway analysis for 
detecting cancer outcome. The main challenges that we faced in this research are as follows: a) 
Biomedical dataset for detecting cancer biomarker is limited in size as the dataset is confidential 
and patient’s personal information. Moreover, the publicly available dataset is limited in sizes and 
samples. We applied augmentation technique to enhance the dataset to fed it into the deep neural 
network. b) Due to limited size overfitting issue can come in biomedical image analysis. Transfer 
learning with fine tuning would be an answer but sometimes there has some performance issues 
that we cannot rely on.   c) CNN model is overly used for image classification, but the performance 
is not satisfactory, therefore, ensemble model could be a good choice for cancer biomarker 
detection. d) In terms of microarray gene expression data analysis, there are huge number of 
features to deal with. Extracting and selecting significant feature would be a great challenge for 
analyzing the data for predicting metastasis. e) Research showed that association study of 
radiological data, histological data, and genome sequences provide significant performances for 
disease diagnosis. It is challenging to collect biomedical image, genome sequence, histology image 
dataset for the same sample. f) Secured sharing of image and genomic information in a distributed 
system is a great challenge when analyzing the confidential patient data. Blockchain technology 
with privacy preserving technique can be applied. 
 Contribution  
The main impacts of this research are: 
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1. An investigation of existing techniques for cancer detection and classification from 
biomedical images and genome sequences. 
2. A novel automatic segmentation and classification method using deep learning. Transfer 
learning approach is used when the limited biomedical dataset attained. 
3. Performance measurement techniques applied to show the robustness of the model 
comparing state-of-the-art methods. 
 Outline of the Whole Report  
The rest of the thesis is structured as follows: 
 Chapter 1 discusses the thesis objectives and highlights the research contributions and 
challenges. 
 Chapter 2 provides a brief study of biomedical imaging modalities, classification, 
segmentation, and gene expression analysis with blockchain technology. 
 Chapter 3 introduces a fusion based approach for lung nodule identification and 
classification. 
 Chapter 4 proposes an ensemble of convolutional neural network for microscopic image 
classification based on breast histological image and cervical cancer image. 
 Chapter 5 establishes a segmentation method using deformable convolutional w-net based 
on three different datasets.   
 Chapter 6 presents an ensemble approach for microarray gene expression classification 
for breast and colorectal cancer. 
 Chapter 7 proposes an association study for radio-genomics and histo-genomics analysis 
for predicting disease biomarkers. 
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 Chapter 8 describes the blockchain based framework for secured sharing of biomedical 
contents in a distributed environment.  
 Chapter 9 recapitulates the research findings and delivers the objectives of future research 
with concluding remarks. 
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2 RELETED WORK 
In this chapter, we contemplate an outline of certain background notions of the subsequent 
segments of this thesis. We provide a summary of medical imaging techniques with the theoretical 
background are vital for diagnosis of cancer.  
 Biomedical Imaging 
Biomedical imaging plays an essential role for the diagnosis of cancer stages and hence it is 
very crucial in healthcare system now-a-days. Medical images can be obtained from different 
imaging modalities (or techniques) which provide a reliable and non-invasive assessment of 
diverse cancers [5]. Medical image analysis can extract the meaningful information about the 
different aspects of diseases conditions. The images are a collection of numerical values as the 
picture elements known as pixels. In an image, each dimension consists of the number of pixels 
define the resolution. In an image, 8,294,400 number of pixels are in a resolution of 8.3 megapixels 
that consists of 3840 × 2160 pixels. Volumetric image of a medical image is the sampled 2D images 
form 3D image in three dimensions lengthways [6]-[7]. The voxels refer as a 3D volumetric image 
that translate the three-dimensional associations among 3D pixels. Using image processing 
techniques both 2D and 3D images encoded information can be extracted and interpreted. 
 
Figure 2.1 Image Pixels, Voxels, and Resolutions. 
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Contrast resolution is a set of concentration colors of red, green, and blue (RGB) that is 
possible to separable in both colored and greyscale image. In Figure 2.1 shows a 2D and 3D 
volumetric image. Pixel and voxel are pictured in two dimension and three-dimension arrays of 
grid. 
 Biomedical Image Modalities 
Different types of imaging modalities are used by modern healthcare for cancer diagnostic 
and for treatment by attaining different features of a human body. These techniques are split into 
two classes based on approaches and process in for visualizing diverse features of disease. These 
are Anatomical and Physiological imaging. Normally Anatomical image captures and pictures the 
structures of anatomy of the range of interest (ROI) in two or three dimensions [8]. These images 
assist doctors to understand and assess conditions of disease for diagnosis. These images also assist 
to identify the response for a specific treatment evolution. For capturing the metabolic condition 
of the ROI is responsible for the functional imaging. This will help the physicians to evaluate the 
physiological conditions of patients to recognize the structural anomalies like tumors.  
Normally an anatomical clinical modality uses X-ray image, computed tomography (CT) 
and magnetic resonance imaging (MRI). Single-photon emission computed tomography (SPECT) 
and positron emission tomography (PET) are included in functional imaging [9]. These imaging 
techniques generate a single image or generate image volumes. This called single-modality 
medical imaging.  
Now a day for cancer diagnosis multi-modality imaging like PET/CT and SPECT/CT 
becomes popular diagnosis procedure in clinical studies and in medical research.  
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 Magnetic Resonance Image (MRI)  
This is the most used imaging technique in cancer segmentation, diagnosis, and prediction 
in modern clinical conditions. MRI uses blend of several X-ray to create tomographic images. In 
the Figure 2.2 shows a CT image of the brain.   
 
Figure 2.2  Brain MRI Image of NSCLC Dataset 
 
 Computed Tomography (CT)  
It is one of the most exploited imaging modalities for detecting cancer, diagnosis, and 
prediction. It makes also use blend of numerous X-ray to generate tomographic images. Figure 2.3 
shows CT image of the lung field of Non-Small Cell Lung Cancer (NSCLC). 
 
Figure 2.3 NSCLC CT Scan Dataset 
 Histological Images  
Histopathological imaging is the golden measurement for diagnosis cancer. This is the 
result from biopsies of tumor tissue. The samples of tumor tissue are marked, then collected and 
then mounted onto glass slides for graphical examination. This assist to picturing the cellular 
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structures ROIs of tumor. This also gives information on types of mutated cell and therapeutic 
insights.  
 
Figure 2.4 Breast Histology Image of BreKHis Dataset 
 
High-resolution whole-slide-imaging (WSI) in histopathology that facilitated the 
numerical evaluation of tumor histomorphometry as well as its involvement with clinical methods 
for cancer diagnosis [10, 11]. Similar to CT images, digital WSI enables medical image analysis 
techniques to be applied to extract image features of abnormal cells. Image traits can then be 
exploited to correlate to genetic profiles of the tumor. Figure 2.4 shows the presence of sentinel 
lymph node in breast cancer metastases. 
 Medical Image Classification  
This part represents different methods of medical image classification that shows the 
authentication of our claims. It is shown here that the existing automated image classification 
approaches to associate with the manual image classification to assist the experts and reflect their 
distinct advantages.  
Image classification is said to be the most essential phase of digital image processing. It is 
appealing for a "pretty picture" or an image with the magnitude of coolers signifying numerous 
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features. It is surely useless without knowing the colors meaning. The main two classification 
approaches are Supervised Classification and Unsupervised Classification.  
Supervised classification is responsible in identifying the classes of Information in the 
image. They are called "training sites". For every classification class, to develop a statistical 
characterization the image processing software is used. It is known as "signature analysis". For 
each information class the statistical characterization is created. Then the image is classified 
through reflection of examine for each pixel. It helps to make verdict about the signatures that look 
like most.  
 
Figure 2.5 Supervised Classification [10] 
 
In Unsupervised classification method a huge number of unidentified pixels are examined. 
All the pixels are divided into several classed and these are depending on the natural groupings, 
that is depending on values of the pixel. This kind of classification does not rely on analyst 
quantified training data as supervised classification. The pixels within a given region type should 
not be diverse to each other in the same dimension. However, different classes’ data should be 
separated well. 
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 Medical Image Segmentation  
This part describes different methods for segmentation of medical image. In the area of 
medical imagine, segmentation is a process of image dividing. It separates an image in different 
part where it holds a group of pixels that collectedly signify an ROI. It eliminates unconnected 
image areas, thus lessen the complexity.  
In maximum medical applications, segmentation of a medical image is described by an 
expert physician is count as golden standard. For cancer patients medical image segmentation are 
trusts upon the visual examination of images and the manual description of tumor ROI. Figure 2.6 
gives the ROIs in different section of medical image modalities. These are defined by qualified 
physicians.   
 
Figure 2.6  Region of Interest (Lung Cancer) in a CT image 
 
Automated segmentation of medical images helps practitioner immensely to identify lesion 
in medical images by gathering useful information that may lead to take necessary action. Several 
architectures have been proposed for medical image lesion detection and segmentation tasks. 
Semantic segmentation has been overly used last couple of years that incorporating various 
structure like U-net, V-net, Y-net, and W-net. Figure 2.7 depicted a diagram on W-net for medical 
image segmentation and analysis tasks.  
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Figure 2-7 W-net for Image Segmentation [11] 
 
 Gene Expression Profiling  
The visual examination is measured only the diagnosis scheme of tumor histopathology. 
But sometimes the diagnosis error is found in tumor classification due to graphical unclear 
morphological properties. A quantitative perception can be obtained as Gene expression profiling 
facilitates tumor identification and predicting for the future clinical diagnosis for the cancer [12]. 
This subsection is mainly designed for genes core concept, its expressions and application in 
medical studies.  
A definite region of the deoxyribonucleic acid (DNA) strands for a gene. It can achieve 
ribonucleic acid (RNA) using genetic codes through transcription. Synthesizing proteins is the 
characteristics of RNAs to encode biological functions through translation. DNA change or 
damage is very common as the genetic codes allow mutation and permanent alteration of genetic 
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elements. However, the change in DNA, mutations could be resulted in changes in functions and 
behavior of genes. The multiple prognosis of cancer genes is the result of mutation according to 
the evidence of Clinical studies. Gene expression profiling is responsible for the patient’s genetic 
information and the application of individual precision medicine.  
Gene expression profiling depends on the invasive surgical procedures. So, the use of gene 
expression profiling is controlled although its significance in the diagnosis and prediction of cancer 
patients. Unfortunately, strong phenotypic and genetic heterogeneity is seemed to allow the cancer 
growth for an individual manifesting at multiple sites. The different characteristics of treatment 
depends on the varieties in gene expressions across multiple sites. 
 Learning Algorithms   
In medical image processing the machine learning has added a great vale. The Machine 
learning techniques increase the ability to develop the automated algorithm in clinical studies. To 
develop any computer aided system the expertise in this field is the demand of time. One of the 
subbranch of machine learning the class of Deep learning which requires to train multiple train 
data level. For example, the convolutional neural network is the implementation of deep layers 
which can extract the potential image feature [13]. This section emphasizes the principles of deep 
learning models especially the CNNs architecture because they present the current sophisticated 
image in recognition of the object of the image. The relevant architecture of CNN model is given 
bellow.  
 Artificial Neural Network 
ANN introduces the machine according to the biological principle of human brain structure 
[14]. It forms nodes said as "artificial neurons" and builds a graph structure of neural network. The 
machine learning uses to extract the nonlinear relationship of experiment data by ANN. The 
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artificial neuron processes and transmits signals using the network of ANN as same as biological 
synapse. ANN needs to achieve an optimal architecture to harmonize network weights and bias to 
get the appropriate outcome. 
In ANNs the basic building blocks are the neuron. Using Figure 2.8 it is clear how the 
neuron takes multiple input values and produce a single output value. Here the input vector is X of 
n elements, the weight vector is W for the same number of elements, equation 2.3.1 summarizes 
the whole scenarios: 
L (𝑊, 𝑋) = Σ 𝑋=0 𝑛𝑓 (𝑥𝑖, 𝑤𝑖) + bias                                     (2.1) 
 
Figure 2.8  Single Layer Neuron [12] 
 
In single model of neuron depicted in Figure 2.8 contains ANN training processes. To 
transmit the component of training data it uses the form of feature vector. The classification is 
conducted in two parts; each neuron is multiplied by its internal weight, then performs on the input 
vector whether it is above or below the threshold value.  
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 Machine Learning 
The modern healthcare system depends much of the principle of machine learning. Main 
principle of machine learning is to recognize the pattern using intelligence mathematical model. 
The goal is achieved by classification and retrieval of image, in tumor image section. The basic 
machine learning techniques as ruled-based system is developed the models of artificial 
intelligence. It is essential to "teach" to identify the distinctive features of patterns in machine 
learning for the data in order to produce outputs of money. Typically, learning methods are divided 
as: supervised, unsupervised and reinforcement learning. 
While multiple disciplines of observable and reinforcement learning demonstrate strong 
potential. The marked medical imaging data is used to discover region-specific genetic 
associations. Since the outcome to this work are primarily related to supervisory methods, we only 
need them here. 
 Training Data: is the repository of data to train a model used in machine learning. The 
training data presentation and its future relationship is obtained by machine learning model. 
 Validity data: is a distinct data set to monitor the training process. This data set is made 
compare the output data with the predicted one by the training data labels. The performance 
of unseen data is approximate by the model parameter. 
 Test data: is a collection of recorded data to measure the accuracy of the model after the 
training process is completed. The test data shows the effectiveness of the trained model. 
Test data is not including in the process of training.  
 Deep Learning 
In-depth learning is classified as a section of machine learning techniques; this allows 
multiple processing-level calculation models to learn multiple levels of abstraction from the 
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internal representation of input data. It performs a limited task of traditional thematic machine 
learning method to process ordinary data in its raw form depth. Deep learning solves this problem 
by solving abstract representations from high-level understanding of input datasets, to low-level 
learning and interpreting multiple processing levels. This is accomplished by continuously giving 
raw information through a continuous multilayer architecture, where the deeper layers have 
learned abstract representations from the representations of the previous layers. 
The multilayer model for teaching under the supervision of in-depth teaching strategies 
employs error propagation or "backpropagation" for training [15]. Back proposition calculates the 
gradient of the ANN's weight-related error function and moves the gradient backwards through 
the neural network. The backflow of error gradients allows for efficient calculation of gradients 
for ANNs. 
GPUs are used to advance the effectiveness of the training process from 10 to 20 times 
compared to usual therapeutic training methods in standard CPUs through the application of deep 
learning techniques.  
2.9.3.1 Convolutional Neural Networks 
It is a special type of ANN that is designed to work with input data in multidimensional 
arrays form, such as color two dimension that contain 2D arrays for each RGB channel. CNN 
training is easier and generalized. It is organized in different phases, and each phase has a special 
layer with unique functions. CNN's building blocks have three specialized layers: convoluted, 
pooling, and activation. 
The convoluted layers contain units that organized in feature maps’ form. Its each unit is 
linked to local patches via a set of weights from the previous layer referred to as the filter bank 
shown in Figure 2.9. The sum of the results of the local filter bank is conveyed over a linear 
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activation layer. Having same kind of feature map is shared with the same filter bank. This value 
allows evolutionary layers to identify local combinations of local properties from the preceding 
layer. Because of highly connected probability of local values and swap locations at the input of 
an image. 
Pooling layers are for merging features in three-dimensional closeness that has semantic 
similarities. The principle behind the pooling layers is to locate the themes which are usually 
formed by highly connected features through a thick granular method.  
CNNs are stimulated by the transmission of biological signals over cells with various 
complexities and different functions in visual neuroscience. CNNs use compositional orders in 
ordinary signal processing.  
The high-level features output from a combination of low-level features. In the images, 
objects combine edges, motifs, and parts. CNN has made great strides in the sophisticated industry 
in multiple branches. CNN has been used mainly in medical image examination to perform 
multiple tasks. These include image segmentation, classification, and identification of diseases.  
Google net, a deep CNN architecture submitted in 2014 as part of the ImageNet Large-
Scale Visual Recognition Challenge 2014 (ILSVRC14). It has 22 levels. Google Net is created to 
performance as a classifier for images of nature. 
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Figure 2.9 CNN with Convolution Layers [15]. 
 
It included the fundamental concept of increasing width and depth. Between this work it is 
keeping calculation costs constant. In the sophisticated region of time, Google net showed 
significant improvements. 
 Performance Evaluation Metrics  
In image retrieval and classification, performance evaluation can be measured with a 
variety of metric accuracy and retrieval metrics commonly used in these domains. In image 
retrieval, accuracy refers to the percentage of true positive images and this percentage of true 
positive images regained in all relevant images in the datasets. This describe as below: 
      𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 = 𝑡𝑝 / 𝑡𝑝 + 𝑓𝑝                                                      (2.2) 
     𝑅𝑒𝑐𝑎𝑙𝑙 = 𝑡𝑝/ 𝑡𝑝 + 𝑓𝑛                                                             (2.3) 
Where true is the number of positive or relevant retrieved images, false positive or 
irrelevant retrieved images and false negative or relevant retrieved images. Therefore, the accuracy 
measures the accuracy of the recovery, where the recovery measures the ability to recover relevant 
items from the database. Another metric that can be used for evaluation purposes is the F-score 
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metric, which is matched with accuracy and can vary in varying degrees depending on the use 
score: 
𝐹𝑠𝑐𝑜𝑟𝑒 = (1 + 𝑠𝑐𝑜𝑟𝑒2) 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 . 𝑅𝑒𝑐𝑎𝑙𝑙 / 𝑠𝑐𝑜𝑟𝑒2 . 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 + 𝑅𝑒𝑐𝑎𝑙𝑙          (2.4) 
 
Therefore, increasing the score may increase the weight of the recall metric from accuracy 
and vice versa. In the image classification, the accuracy of a classifier at the test stage is a true 
positive number compared to the total classified examples. 
 
 Blockchain  
During this age of digitalization, the health care sector needs to more secure way to transfer 
data between different stakeholders. The number of health care data is also is big enough to handle 
with great sensitiveness. Medical data has different types of formatting and representation. These 
data include health records, images, sensor data, genome sequences, bills, and payments and many 
more. Collecting and combining all these data can help to get run machine learning and different 
analysis to get inside information. This information will be very valuable for different sector from 
medical center to patient and between them many other actors. 
Making a common intelligent system for medical information management, it is very important 
to bring all format of data in a common format that they can understand each other. This system 
data is increasing every second. So, volume of the dataset also a big challenge to handle in this 
system.  
The GDPR and HIPAA are two regulations in Europe and United states as advocate 
patient's privacy. This describe the law about the rights of a patients to give access to their medical 
data [16]. It is given the data protection of a patient. To build a total electronic health care system, 
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it is crucial to keep information confidential from different level of stakeholders according to the 
permission of the patient. In the electronic health care system, maintaining the data, giving 
permission to different stakeholders, formatting the data for all platform, all these increase the 
system complexity and through a big challenge. 
Health care eco system ensuring the security of the health record and share this data in 
secure way to national and international wide. For this need a common architecture for share with 
different actors in the system. 
 
Figure 2.10 Healthcare Related Blockchain Project [16] 
Blockchain could be a game changer in this filed with high security and in the distributed 
form. This technology gets the attention of both academia and industry. This technology employs 
complete control to a single user with giving fully controlled from a central point. For sharing 
health care, this technology enhances the privacy-preserving data. In the scenario of chronic 
diseases, data need to share between different physician to get multiple medication. For getting 
better treatment of chronic diseases, may need to go different places for different types of 
23 
medication. Using blockchain technology the data could share in a secure way. This technic 
optimized the supply chain process. It is now crucial to implement the blockchain in the medical 
information eco system to share the information in secure process and give patient a optimized 
solution for his/her treatment. 
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3 LUNG CANCER DETECTION AND CLASSIFICATION IN CT IMAGERY USING 
HYDRA-NET WITH FEATURE FUSION 
In this chapter, we contemplate an outline of certain background notions of the subsequent 
segments of this thesis. We provide a summary of medical imaging techniques with the theoretical 
background that are crucial for cancer diagnosis.  
 Introduction 
Deep learning is a new branch of machine learning techniques that involve with high level 
data abstractions by considering a series of non-linear transformations. The complex model 
architectures followed by these algorithms to achieve better performances from large-scale 
unlabelled data and it passes through several hidden layers to identify and extract the complex 
features that finally produce an output. The deep learning uses previous layer computations in 
terms of identifying features and that is a power of the technique [17].  In recent years, deep 
learning has great impact on medical data processing, like lung cancer detection, skin cancer 
detection, etc. Lung cancer is the most dangerous cancer for a human being that increasing in an 
alarming rate with $12 billion in health care costs yearly in the US. Doctors are fully depending 
on the CT scans but could not be able to identify the disease. Therefore, computer aided support 
is needed for the doctors to make their job easy and that can reduce the death rate due to lung 
cancer. There are several machine learning classification approaches used in past few years by 
the researchers like SVM, RNN etc [18]. However, to effectively handle the complex structure 
SVM, KNN techniques are not good enough. Therefore, Deep learning technique is a good one 
to handle the complex situation without considering a huge number of nodes that is used in 
traditional machine learning technique like SVM and KNN [19]. It is now growing rapidly in 
different health sectors like bioinformatics, brain image analysis, retinal image analysis etc.  
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In this research, two deep learning approaches has been applied to identify the lung cancer 
from CT scan images. Firstly, an autoencoder approach is used with data pre-processing with u-
net architecture is used for nodule detection. Secondly, a 3D Descent is used for lung nodule 
detection and classification. Finally, a hydra net is used for feature fusion of the two afore-
mentioned model. The proposed hydra model shows significant performance comparing with 
state-of-the-art methods. Several machine learning and statistical techniques was used to detect 
lung cancer nodules with better accuracy rate. The rest of the paper is organized as follows: section 
3.2 considered the datasets. Section 3.3 considered the pre-processing, 3.4 considered the 
methodology and, 3.5 described the experimental results. Finally, the whole paper terminates with 
a summary in section 3.6. 
 Datasets 
In this research, Kaggle datasets used first that enclosed with CT scan images of different 
patients labeled with no cancer and cancer. For the training set, CT scan images from 1397 number 
of patients has been taken and 198 patients CT scan images is considered as test set. Moreover, 
the images are gray scale of size 512 x 512 that is very large, and the images are already labeled. 
Though each patient’s datasets are already labeled, there is no information about the location of 
the nodules.  
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Figure 3.1   Kaggle CT Scan Image 
 
Figure 3.2   LUNA16 CT Scan Image 
 
Figure 3.3   LIDC-IDRI CT Scan Image 
 
In terms of LUNA16 datasets [2][4], the CT scan images of the patients is considered with 
labeled datasets. Moreover, there are some annotations that make it more useful to identify the 
location and classification of nodules. Kaggle dataset contained 25000 gray scale CT scan images 
and the LUNA16 contained 888 CT scan images. Moreover, LIDC-IDRI dataset consists of 686 
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lung nodule samples with 1010 CT scans. The sample image for the three different datasets is 
mentioned in figure 3.1, 3.2, and 3.3. 
 Methodology 
In this section, the pre-processing stages employed in the experiments is explained along 
with the approaches to address the problem.  
 Pre-processing 
The pre-processing steps covers the following areas like segmentation of nodule from lung, 
z-score normalization and finally nodule detection using u-net architecture 
 Lung Segmentation 
Lung segmentation is the key task to work with lung images to identify the lung disease. 
The candidates of the lung nodules regions are considered from the CT scan images. False positives 
reduction has been performed by applying thresholding value calculation technique depending on 
the pixels intensity that separate the lungs pixels from the image. Kaggle and LUNA datasets is 
considered for the segmentation purpose along with the filtering method like erosion and dilation 
to calculate the patches [20]. 
3.3.2.1 Z-Score Normalization 
There are several normalization technique available now-a-days. Max-min normalization 
and z-score normalization technique is overly used in data mining and machine learning arena. In 
this research, z-score normalization technique is used for the CT scan images that subtracted the 
mean to centralize the images. Then the standard deviation is considered to apply division 
technique to complete the normalization process.  
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3.3.2.2 Nodule Detection 
Nodule detection is very important to identify the lung cancer regions from an image. U-
net [8] structure of neural network performs significantly well to segment the images and properly 
detect the nodules. CT scan images is considered from both the dataset like Kaggle and LUNA for 
the segmentation purpose and after carefully segmented the images using U-net architecture, the 
dataset is fed to the deep neural network for classification purpose.   
 
Figure 3.4 U-net Structure for Nodule Detection [21] 
Binary mask output can be obtained after all the processes that represents the specific 
location of the nodule in an image. The U-net architecture for segmenting the images has been 
mentioned in Figure 3.4. The quantity of nodules for specific patient also obtained from this 
process with cancer and no cancer chances labeled mentioned in figure 3.5 and 3.6. 
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Figure 3.5 Quantity of Nodules Identified for a Patient Label Zero 
 
 
Figure 3.6 Quantity of Nodules Identified for a Patient Label One 
3.3.2.3 Convolutional Autoencoder Approach 
Convolutional autoencoder approach is very popular for lung nodule detection from CT 
scan images where the image patches are considered from the lung input images. After detecting 
the patches from with a view to identify the nodules in the images, encoding operation is performed 
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to represent all the patches in a feature vector. Finally, SVM is used for the classification purpose. 
U-net architecture mentioned before is used for nodule detection.  
3.3.2.4 Autoencoders  
Autoencoder approaches have been considered to identify the lung cancer and eventually 
compared all the processes to come up with the best approach. In the first approach, the patches 
are identified from the CT scans images after detecting the nodules with appropriate pixel values. 
48 x 48 patches extracted from the image and three techniques like autoencoder, local binary 
patterns evaluation, flattening is applied to encode the patches. The feature vector is identified 
from all the patches that generate 64-dimensional vector and eventually fed into the SVM 
classifier.  
The architecture of the autoencoder used here is shown in Fig. 3.7. The convolutional 
autoencoder used in this approach. 
 
 
Figure 3.7 Convolutional Autoencoder 
 
 Local Binary Patterns (LBP) 
LBP is a popular technique also used termed as local binary patterns that generate the 
binary code from the image by calculating the value of the neighboring pixels and update the 
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current pixel value. The feature vector is generated from the n bit number of neighbors and can be 
used to express an image with the binary bit patterns mentioned in figure 3.8. Flattening is the 
method where the raw pixels of the patches is used for encoding purpose and represented using a 
vector [22]. The whole process mentioned in figure 3.8 where a convolutional neural network is 
used. 
 
 
Figure 3.8 Local Binary Pattern for an Image Patch 
3.3.3.1 Flattening  
For encoding the candidate patches raw pixel patches is used to form a vector. In here 48 
x 48 patches is simply used as a vector. In terms of patient level representation, a feature vector is 
needed for each patient to describe whether the patient experienced lung cancer disease or not. 
Finally, the average value of encoding is considered based on all the patches to represent the final 
feature vector. 
 3D DenseNet Approach 
The DenseNet architecture consists of 3D convolutional neural network with sequence of 
Dense block and transition layer. The performance of 3D DenseNet is exceedingly high comparing 
with other state-of-the-art deep learning model as the overall distance in between input to the 
output is less. Due to the architecture with shorter distance, the better optimization result can be 
obtained as the vanishing gradient would be enhanced. The overall architecture of 3D CNN is 
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mentioned in figure 3.8 where the 3D volumetric image is used as the input and passed through 
the 3D convolutional layer and the sequence of Dense block is considered along with transition 
layer and finally fully connected layer is used with softmax to classify the value. In this approach, 
lung cancer 3D CT scans is used as input, rather than 2D CT scans. In this model, 3D volumes of 
shape 120 x 512 x 512 is considered with the batch size of 32. 
 
Figure 3.9 3D DenseNet. 
 Hydra Net Approach 
An ensemble of deep neural network is considered for forming a hydra net architecture. 
The training set, initial weights, and the number of layers is varying tremendously to form the 
hydra net architecture. In our proposed approach, we considered the 2D CNN and 3D DenseNet 
of different architecture to combine and form the hydra net structure. The important thing of this 
kind of network is it is complex and time consuming to deal with different weight from initial to 
final layer with varying structure. Hydra architecture considers various transformation based on 
geometry in terms of the training samples of the network.  
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Figure 3.10   Hydra Net 
Moreover, hydra net calculates the results by combining the values of the heads with score 
vector that represent the classification. Therefore, each produces a score vector result and all the 
head score values is considered. Finally, the values with highest majority voting would be 
considered for identifying the final label. Depending on the number of heads and number of votes, 
we can determine whether there are false positives or not.  
 Experimental Results 
All the methods that were used in this research was implemented in python with other 
essential libraries like NumPy, Scikit-Learn, TensorFlow, Keras. In terms of performance 
evaluation, the U-net architecture is considered for detecting the nodules with true positive rate of 
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85 percent and the 65 percent for training and test datasets where the LUNA16 was considered. 
The hardware and software system specification are mentioned in Table 3.1 
Table 3.1   Hardware and Software Description 
Hardware Software 
Processor: i7-6000, 2.80 gigahertz OS: 64-bit Windows 10 
Primary Memory: 16 gigabytes RAM API: Keras [50] 
GPU: NVIDIA GeForce GTX 770 Backend: Tensorflow [51] 
Storage: Solid State, 250 gigabytes Language: Python 3.7.3 [52] 
 
This experiment evaluates the computation result using the parameters, such as accuracy, 
specificity, sensitivity, and F-score. These parameters are achieved using True Positive (TP), False 
Positive (FP), True Negative (TN), False Negative (FN) derived from the confusion matrix. 
Equation (3.1) to Equation (3.5) represents the computing formula of these five performance 
parameters from the value of confusion metrics. 
                                   𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 (𝐴𝐶𝐶) =
𝑇𝑃+𝑇𝑁
𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁
                                                    (3.1) 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 (𝑆𝑃) =
𝑇𝑁
𝑇𝑁+𝐹𝑃
       (3.2) 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑆𝐸) =
𝑇𝑃
𝑇𝑃+𝐹𝑁
       (3.3) 
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 (𝑃𝑅) =
𝑇𝑃
𝑇𝑃+𝐹𝑃
        (3.4) 
𝐹 − 𝑠𝑐𝑜𝑟𝑒 (𝐹𝑠) = 2 ×
𝑆𝐸×𝑃𝑅
𝑆𝐸+𝑃𝑅
       (3.5) 
To evaluate the performance of the U-Net, we assumed that a nodule was detected correctly 
if the U-Net detected a nodule within 10 pixels of its correct location in the annotated mask. The 
U-Net described in 3.2.1 achieved a true positive rate of 85% and 65% on train and test sets, 
respectively, of the LUNA16 dataset, and an average false positive rate of 0.14 and 0.4 per slice 
on the same, respectively. 
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The log loss can be formulated as: 
                𝐿𝑜𝑔𝐿𝑜𝑠𝑠 = −
1
𝑛
 ∑ [ 𝑦𝑖log (𝑦𝑖)̂ + (1 −  𝑦𝑖) log (1 − 𝑦𝑖) ̂
𝑛
𝑖=1
]                                 (3.6)  
Where, n is the number of patients in the test set 
^yi is the predicted probability of the image belonging to a patient with cancer 
yi is 1 if the diagnosis is cancer, 0 otherwise 
The Kaggle dataset contains CT scans from 198 patients that are not labelled, these patients 
form the test set for the submission on which we are scored. 
Table 3.2   Model Comparison 
Method Accuracy Log Loss 
2D CNN 81.21% 0.43257 
3D DenseNet 84.74% 0.42865 
 
From Table 3.2 it can be observed that, 3D DenseNet achieved better result compared with 
2D CNN method where the log loss is near about 0.42. In 2D CNN, U-net architecture was used 
along with three auto encoder techniques that performs significantly better than using raw datasets 
directly into the classifier and heatmap techniques. 3D DenseNet performance is not better than 
2D CNN. The accuracy of the dataset is achieved where 20028 samples is considered for the 
training set and the 9866 samples is used for the validation purpose with different epoch values.  
Table 3.3   Comparison with the State-of-the-art Method 
Method Accuracy 
Multi-Scale CNN [10] 86.84% 
Vanilla 3D CNN [11] 87.40% 
Hydra Net 91.75% 
 
From Table 3.3 it can be observed that, multi-scale CNN shows the accuracy result of 
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86.84. The other deep learning models is compared with the proposed hydra net. The performance 
of the hydra net shows better accuracy results comparing with the other model as the different 
architecture with different weights is considered in hydra net. Finally, the majority voting scheme 
with strengthen vanishing gradient enhance the model performance. 
 Summary 
 Lung cancer detection has been a key research area last couple of years. The researcher 
has applied several methods to improve the performance of the computer aided process. 
Classification methods play key role to identify the nodules from the images with better prediction 
rate. In this research, two methods are considered to evaluate the performance. U-net architecture 
is used for nodule detection purpose. Convolutional neural network is used as the classification 
purpose and have shown greater performance along with autoencoder, binary patterns and 
flattening. The performance of the 3D DenseNet is superior than the 2D CNN with better log loss 
value. Moreover, the ensemble hydra net performs better than the single deep neural network 
model. 
 
 
 
 
 
 
37 
4 MICROSCOPIC IMAGE CLASSIFICATION USING ENSEMBLE OF DEEP 
CONVOLUTIONAL NEURAL NETWORK  
 Introduction 
Microscopic image study has great impact for cancer detection and classification and the 
practitioner is fully focusing on the images to attain valuable information.  Early detection and 
diagnosis can boost the possibilities of endurance rate of the cancer. Cancer is extremely spreading 
in the world and become the prominent cause of mortality of the mankind. Mammography and 
biopsy are the two overly applied methods for cancer disease diagnosis. Radiologist is fully 
responsible for early detection of the cancer in mammography whereas tissue is considered for 
biopsy in terms of detecting cancer. It is important to identify the cell where cancer occurred based 
on the shape, size, degree of malignancy, and distribution of tissue.  However, identifying 
cancerous cell by visually inspecting it is time consuming and laborious task. Moreover, expert 
pathologist needed to go through the process and sometimes it is hard to identify cancerous cells 
from bunch of images. Therefore, effective identification of cancerous cell may lead to biopsy and 
may reduce the chance of infection and mortality [24]. 
Latest advancements in machine learning and image processing have facilitated the 
improvement of computer-aided diagnosis (CAD) systems for identifying and analyzing breast 
cancer and cervical cancer from the microscopic images more smoothly and faster way with higher 
accuracy results. The CAD system analyzes the microscopic images of the sample tissue, and finds 
the patterns corresponding to the cancerous and non-cancerous condition and classifies the images 
respectively into benign and malignant class. The major challenges associated with the 
classification of breast and cervical cancer images include the inherent complexity in microscopic 
images such as cell overlapping, subtle differences between images and uneven color distribution. 
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The objective of this study is to develop an accurate and reliable solution for breast cancer and 
cervical cancer classification.   
In this study, we have analytically examined the deep learning models for automated 
identification of breast cancer. Key features of this work are as following: 
 Deep convolutional neural network with transfer learning is considered to detect breast 
cancer and cervical cancer from microscopic images  
 Data augmentation technique including rotation, cropping, flipping, and resizing has 
performed for image augmentation. 
 Examined the performances of deep ensemble model with the state-of-the-art breast 
histology and cervical cancer image classification methods. 
This chapter is organized as follows: Section 4.2 describes the proposed method for 
classification of benign and malignant histopathological images and cervical images. Section 4.3 
describes the dataset and data augmentation method. Section 4.4 presents the evaluation metrics 
along with the experimental results. Finally, the conclusion is drawn in Section 4.5. 
 Methodology 
In this research, we introduce a novel deep neural network architecture for microscopic 
image classification using transfer learning. In the proposed architecture, three state-of-the-art 
CNNs are used to extract features using transfer learning and fine tuning. The pretrained CNN 
models such as Xception [25], Resnet [25], and Inception-Resnet-v2 [25] would be considered as 
feature extractor for the proposed ensemble model for microscopic image classification. The 
overly applied environmental image dataset known as ImageNet dataset is employed with these 
CNNs. ImageNet consists of millions of natural images can be applied for biomedical images as 
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the dataset is small. The extracted features from each pre-trained CNN would be combined in fully 
connected layer for microscopic image classification.    
Google’s inception CNN model is extended to develop Xception [25] model by 
incorporating detpthwise separable convolutions and it has gained significant performance and 
have been applied for biomedical image analysis and applications. As different sized convolutional 
filters used in this model it reduces the number of hyperparameters as well as computational 
complexity. The Xception module is robust, stronger than the Inception module, and major 
composition inside the pretrained Xception architecture, as demonstrated in figure 4.1. 
 
Figure 4.1   Pre-trained Xception [25] 
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Resnet is a deep residual network that consists of multiple neural networks with sequence 
of convolutional connection. In here we considered Resnet152, thought there are other Resnet 
version with different depth. Resnet152 is overly used for biomedical image classification and 
shows significant performance. It reduces the running time and computational complexity by 
decreasing the number of parameters. Figure 4.2 illustrates the basic architecture of Resnet152. 
 
Figure 4.2   Pre-trained ResNet-152 
 
Inception-Resnet-v2 [25] consider the blended of Inception CNN structure and Residual 
connection to form the new architecture. A sequence of convolutional layer with max pooling 
operation is considered in Inception-ResNet-v2 structure with the bunch of residual connections 
that decreases the running time of the network. Figure 4.3 shows the basic network architecture of 
Inception-Resnet-v2.  
 
Figure 4.3   Pre-trained Inceptoin-ResNet-V2 
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 The Proposed Ensemble Model 
The proposed ensemble model is the combination of three pre-trained CNN model 
mentioned above. ImageNet dataset is used consists of millions of nature images that is used to 
train the three pre-trained CNN model by incorporating the transfer learning approach. Deep CNNs 
are proficient to discover basic image features that are appropriate to further image datasets without 
training from scratch. Figure 4.4 illustrates the transfer learning structure for a single CNN with 
fine tuning. The pretrained networks function as a feature extractor for generic image features and 
the two last layers are fully connected layers for classification. The details of the features generated 
by the pretrained deep CNNs are summarized as follows. 
 
 
Figure 4.4   Ensemble Model for Breast Histology Image Classification  
 
In proposed ensemble model, the voting approach is used. The output of different pre-
trained CNN model majority voting is used and the class with most votes is considered as decisive 
label for test sample. 
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 Datasets 
Microscopic image dataset of breast cancer and cervical cancer is considered in this 
research. Breast cancer datasets with sub-types were collected from BreaKHis (The Breast Cancer 
Histopathological Images) [26]. BreaKHis consists of 7,909 pathological breast cancer images. 
The dataset with different magnification of 40X, 100X, 200X, and 400X from 82 patients were 
selected for sub-types classification. The number of benign images is 2,480 and the number of 
malignant images is 5,429 malignant. The dataset contained four distinct histological sub-types of 
benign breast tumors: adenosis, fibroadenoma, phyllodes tumor, and tubular adenona; as well as 
four malignant tumors: ductal carcinoma, lobular carcinoma, mucinous carcinoma, and papillary 
carcinoma.  
 
Figure 4.5   BreaKHis Dataset for Histopathological Images  
In Table 4.1, BreaKHis dataset with different magnification factor is mentioned for 
different number of patients with benign and malignant classes. The dataset is split into training 
and test set. Approximately 80% of available data were chosen for the training set and remaining 
20% of the data were used for performance evaluation. 
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Table 4.1 Number of Patients with Magnification Factor for BreaKHis Dataset. 
  Magnification Factor 
Class 40X 100X 200X 400X Number of Patient 
Benign 625 644 623 588 24 
Malignant 1370 1437 1390 1232 58 
Total 1995 2081 2013 1820 82 
 
In terms of cervical cancer, two overly used benchmark dataset is considered named PAP-
smear dataset and 2D-Hela dataset. PAP-smear contains 917 microscopic images with benign and 
malignant. The 2D-Hela dataset contains microscopic images of 862 with 10 different categories 
[27]. In Figure 4.6, the sample of 2D-Hela dataset is mentioned and in Figure 4.7 representing 
PAP-smear dataset. 
 
Figure 4.6   Cervical Cancer 2D-Hela Dataset 
 
 
Figure 4.7   Cervical Cancer PAP-smear Dataset 
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 Data Augmentation 
Data augmentation is a crucial phase to consider when the dataset is too small to have 
sufficient samples to be considered to train a deep neural network with a view to perform features 
extraction process. The necessity of image augmentation is crucial to achieve better performance 
in deep learning classification model. The data augmentation process is applied for microscopic 
images both for breast histopathological images and cervical cancer images. Augmentor Python 
library [27] is used to perform the data augmentation process including random resizing, rotating, 
cropping, and flipping methods depicted in Figure 4.8. 
 
Figure 4.8   Data Augmentation Techniques including Rotating, Cropping, Flipping, and 
Resizing. 
 
The input image (a) in the dataset is augment or rotated into 90-degrees (b) and 270 degrees 
(c). Then, image flipped (d) top bottom to right with 0.8 probability. Next image was cropped (e) 
with probability of 1 and percentage area of 0.5. Finally, input image was resized (f) with 
width=120 and height=120. 
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 Results and Experiments 
The proposed ensemble model with three pre-trained deep CNN model is considered for 
microscopic image classification. Technically, Python programming language with Keras and 
TensorFlow is used for the classification purpose [28]. The hardware and software system 
specification are mentioned in Table 4.2. The data augmentation technique is used to enhance the 
dataset as the breast cancer and cervical cancer dataset is too small to avoid overfitting. The dataset 
is split into training, validation, and testing set. The distribution of the dataset is 70% as training 
data, 10% as validation data and 20% as test data. The CNN model configuration is mentioned in 
Table 4.3 with batch size, optimizer, input size, and learning for each model. 
Table 4.2 Hardware and Software Description 
Hardware Software 
Processor: i7-6000, 2.80 gigahertz OS: 64-bit Windows 10 
Primary Memory: 16 gigabytes RAM API: Keras [50] 
GPU: NVIDIA GeForce GTX 770 Backend: TensorFlow [51] 
Storage: Solid State, 250 gigabytes Language: Python 3.7.3 [52] 
 
Table 4.3   CNN Model Configuration 
Model Input Size Batch Size Optimizer Learning Rate 
Resnet152 299 x 299 12 RMSprop 0.045 
Xception 299 x 299 12 SGD 0.045 
Inception-ResNetv2 299 x 299 12 RMSprop 0.045 
 
This experiment evaluates the computation result using the parameters, such as accuracy, 
specificity, sensitivity, and F-score. These parameters are achieved using True Positive (TP), False 
Positive (FP), True Negative (TN), False Negative (FN) derived from the confusion matrix [29]. 
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Equation (4.1) to Equation (4.5) represents the computing formula of these five performance 
parameters from the value of confusion metrics. 
                           𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 (𝐴𝐶𝐶) =
𝑇𝑃+𝑇𝑁
𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁
                                  (4.1) 
         𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 (𝑆𝑃) =
𝑇𝑁
𝑇𝑁+𝐹𝑃
       (4.2)  
         𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑆𝐸) =
𝑇𝑃
𝑇𝑃+𝐹𝑁
       (4.3) 
                         𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 (𝑃𝑅) =
𝑇𝑃
𝑇𝑃+𝐹𝑃
                      (4.4) 
         𝐹 − 𝑠𝑐𝑜𝑟𝑒 (𝐹𝑠) = 2 ×
𝑆𝐸×𝑃𝑅
𝑆𝐸+𝑃𝑅
       (4.5) 
The accuracy comparison of the three pre-trained method for breast cancer images is 
mentioned in Table 4.4 with other measurement technique such as precision recall, and F1-score. 
The accuracy of the individual CNN model along with the ensemble model result was compared 
with other state-of-the-art method.  
Table 4.4   Comparative Study of Different CNN Model Breast Cancer 
Model Accuracy Precision Recall F1-Score 
Resnet152 94.12 0.93 0.95 0.94 
Xception 95.75 0.95 0.97 0.96 
Inception-Resnet v2 94.67 0.93 0.94 0.94 
Ensemble 97.83 0.97 0.99 0.97 
 
The accuracy comparison of the three pre-trained method for cervical cancer images is 
mentioned in Table 4.5 with other measurement technique such as precision recall, and F1-score. 
The accuracy and the standard deviation are combinedly represented in the table below. The 
individual CNN model along with the ensemble model accuracy result was compared with other 
state-of-the-art method.  
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Table 4.5   Comparative Study of Different CNN Model for Cervical Cancer 
Model 2D-Hela PAP-smear 
Resnet152 89.72 ± 2.18 90.87 ± 1.48 
Xception 90.72 ± 1.85 89.66 ± 1.89 
InceptionResnetV2 92.00 ± 1.97 89.25 ± 2.23 
Ensemble 96.72 ± 2.50 96.81 ± 1.75 
                                                                                              (± std) 
Results in Table 4.6 show the accuracy comparison with other methods. The last row of 
Table 4.6 also shows the results from our proposed ensemble method that has significantly 
improved in comparison to recent development study. Figure 4.9 represented the bar diagram of 
the accuracy comparison models.  
Table 4.6   Accuracy Comparison of Breast Cancer 
Method Accuracy (%) 
Nguyen [20] 92.63 
Awan [21] 90.0 
Kensert [22] 97.00 
Vesal [23] 97.50 
Khan [24] 97.52 
Proposed Ensemble 97.83 
 
 
 
 
 
 
 
Figure 4.9   Accuracy Comparison of Breast Cancer Image 
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Results in Table 4.7 show the accuracy comparison with other methods. The last row of 
Table 4.6 also shows the results from our proposed ensemble method that has significantly 
improved in comparison to recent development study. Figure 4.10 represented the bar diagram of 
the accuracy comparison models.  
Table 4.7   Accuracy Comparison of Cervical Cancer 
Method 2D-Hela PAP-smear 
Lazebnik [30] 83.79 ± 2.5 84.03 ± 2.3 
Ojala [31] 81.47 ± 2.1 81.43 ± 2.1 
Liu [32] 86.20 ± 2.5 87.63 ± 2.1 
Lin [32] 89.37 ± 1.5 89.96 ± 1.4 
Long [33] 92.57 ± 2.46 92.63 ± 1.68 
Proposed Ensemble 96.72 ± 2.5 96.81 ± 1.75 
 
 
Figure 4.10   Accuracy Comparison Cervical Cancer Image 
 Summary 
In this article, we proposed a novel deep learning framework for the detection and 
classification of breast cancer and cervical cancer using the concept of transfer learning. In this 
framework, features are extracting from microscopic images using three different CNN 
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architectures which are combined using the concept of transfer learning for improving the accuracy 
of classification. The data augmentation technique is applied to enhance the volume of the images 
and that were fit for the CNN model to improve accuracy results. The performance of the proposed 
ensemble model is contrasted with state-of-the-art CNN model. It has been observed that the 
proposed ensemble model provides outstanding accuracy results without training from scratch that 
increases classification proficiency. 
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5 MULTI-ORGAN IMAGE SEGMENTATION BASED ON DEFORMABLE 
CASCADED W-NET 
 Introduction 
Biomedical image analysis and segmentation has been a key task for investigating lesion 
in different parts of the body based on medical images with a view to collect useful information 
that might be helpful for doctors in terms of disease diagnosis. Automated analysis of medical 
images can reduce the chances of death by identifying and detecting abnormal region from an 
image [34]. Moreover, developments of machine learning and image processing technique have 
facilitated the improvement of computer-aided diagnosis (CAD) systems for incorporating 
segmentation techniques to detect different types of cancer in a faster way with higher accuracy 
results [35]. Extracting features from the images using machine learning techniques has been a key 
concern as the feature extraction processes from the images has enormous complexity. Semantic 
segmentation using deep learning technique has significant impact for lesion detection as it showed 
performances that can be comparable with state-of-the-art method. Semantic Segmentation 
technique has been applied for detecting lesion based on multi-organ segmentation methods of the 
images [36]. Deep learning techniques like U-net, V-net, Y-net, W-net has shown significant 
outcome for cancer lesion detection.  
The objective of this study is to develop an accurate and reliable solution for cancer lesion 
detection and segmentation. We propose a deformable cascaded W-net based on U-net 
architecture. The proposed model shows significant performances for biomedical image 
segmentation [37]. 
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In this study, we have analytically examined the deep learning models for automated 
identification of lesion with a noble segmentation technique. Key features of this work are as 
following: 
 Deep learning technique using a deformable cascaded W-net is considered for semantic 
segmentation of medical images. 
 Data analysis technique based on normalization and image patches generation process is 
applied. Generator network and discriminator network used to identify generator mask and 
annotated mask. 
 Examined the performances of segmentation technique based on deep learning models with 
the state-of-the-art semantic segmentation techniques. 
This chapter is organized as follows: Section 5.2 presents the problem statement. Section 
5.3 describes the proposed method for medical image segmentation. Section 5.4 describes the 
datasets used in this research. Section 5.5 presents the evaluation metrics along with the 
experimental results. Finally, the conclusion is drawn in Section 5.6. 
 Problem Statement 
Medical image segmentation has been a key issue last couple of decades. Unsupervised 
ways were overly used for effective segmentation of the images with pixelwise calculation and 
prediction for segmenting the images to detect objects Several techniques have been introduced 
like Markov Random Field method, Mean Shift method, etc [38]. However, supervised techniques 
get interest recent days in terms of image segmentation. Automated segmentation of the images 
can reduce the processing time and increase the performances of disease diagnosis. Machine 
learning and deep learning models within computer vision area has been shown significant 
outcome for image segmentation [39]. The deep learning models are evaluated based on fully 
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convolutional networks to generate a pixelwise projection. The training of supervised learning 
models is utilized to discover filters to deliver segmentation results on medical images.  
Due to different architecture of the deep learning model, it is not certain which framework 
would be good for semantic segmentation of the images. Deep learning techniques like U-net, V-
net, Y-net, W-net has shown significant outcome for cancer lesion detection [40][41]. However, it 
is hard to play with the medical image dataset for semantic segmentation using deep learning 
techniques as the semantic segmentation models need a substantial volume of pixelwise labeled 
training data to carry out the segmentation task. Moreover, it is really challenging to accumulate 
the vast amount of labeled medical image data [42].  
To solve the medical image segmentation problem, we proposed a deformable convoluted 
cascaded W-net for effective segmentation of the image. The objective of this study is to develop 
an accurate and reliable solution for cancer lesion detection and segmentation. The proposed 
deformable cascaded W-net is basically based on U-net architecture. The proposed model shows 
significant performances for biomedical image segmentation based on end-to-end and pixel-to-
pixel manner [43].  
 Methodology 
The primary goal of this work is to develop a deep learning models for accurate and reliable 
solution for cancer lesion segmentation on medical images. The architecture of the model is fully 
inspired by the overly used U-net architecture [44] and deformable convolutional network [45]. 
We proposed a deformable convoluted cascaded W-net for effective segmentation of the medical 
image for retinal vessel segmentation task, skin cancer lesion segmentation task, and lung cancer 
segmentation task. The proposed approach integrated the two architecture of Cascaded W-net and 
Deformable Convolutional Network.  
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Figure 5.1 and 5.2 showed the architecture of the two networks that integrated to form the 
novel deformable cascaded W-net for medical image segmentation purpose. The input raw medical 
images are pre-processed and generate patches to determine training and validation dataset. The 
patches generated from the three medical image datasets considered in this experiment based on 
patch sizes. The two networks like deformable convolution network and cascaded W-net are both 
end-to-end deep learning structures for semantic segmentation considered a 48x48 patch size. All 
outputs from the deep learning models are organized to produce a comprehensive segmentation 
map.  
 
Figure 5.1   W-net Architecture [46] 
 
Figure 5.1 depicted the cascaded W-net [46] architecture inspired by the architecture of the 
U-net [33] that contains encoder and decoder network with two sides for medical image 
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segmentation. The convolutional layer of the deep learning network was replaced by the 
deformable convolutional block. The new model is trained to integrate the low-level feature with 
the high-level features, and the receptive field and sampling locations are trained to adaptive to 
vessels’ scale and shape, both of which enable precise segmentation. Deformable convolutional 
network used the deformable convolutional block as encoding and decoding unit that integrated 
on top of cascaded W-net. The generator network and discriminator network used to identify 
generator mask and annotated mask by combining with the segmented output. 
 
 
Figure 5.2   Proposed Deformable Cascaded W-net for Segmentation  
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Figure 5.2 illustrates the deformable cascaded W-net architecture consists of a 
convolutional encoder-decoder in a cascaded W-net framework. The deformable convolutional 
block comprises of a convolution layer with a batch normalization layer [47] and an activation 
layer that generate the offset. In terms of decoding, a typical convolution layer has been inputted 
to adapt filter numbers after merge operation. The features can learn on the deformable cascaded 
W-net to produce efficient segmentation results in terms of retinal blood vessel segmentation, skin 
cancer lesion segmentation, and lung cancer segmentation. 
 Datasets 
5.4.1   Retinal Blood Vessel Dataset  
Overly used DRIVE dataset is considered for blood vessel segmentation. The dataset 
comprised of color retinal images of 40 samples. From the dataset 50% of the samples is used as 
training dataset and another 50% of the samples is considered as test dataset. The images are of 
565×584 pixels [48].  In terms of processing the images from DRIVE dataset, 220,000 patches 
were considered and split into training and testing patches of 180,000 patches and 40,000 patches, 
respectively. 
5.4.2   Skin Cancer Dataset  
Skin cancer dataset is considered from the Kaggle skin lesion segmentation competition of 
2017. The dataset consists of 2000 samples and split into training and testing for model accuracy 
measurement. Out of 2000 samples, 1250 samples considered as training set and the rest of the 
750 samples considered as testing and validation samples [49]. 
5.4.3   Lung Cancer Dataset  
Lung cancer dataset is considered from the Kaggle Data Science Bowl of 2017 for 
detecting lung lesion from the CT images. The 2D and 3D CT lung images is used for the 
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segmentation purpose. The size of the images is 512×512 and the dataset is split into training set 
and test set [49]. From the number of images, 80% is used as training set and 20% is used as test 
set.   
 Results and Experiments 
The proposed model is applied for three different datasets for medical image segmentation. 
Technically, Python programming language with Keras and TensorFlow is used for the 
classification purpose. The hardware and software system specification are mentioned in Table 
5.1. Batch size of 32 and number of epochs is considered 150 for all the experiment with optimizer, 
input size, and learning rate of the model. 
Table 5.1 Hardware and Software Description 
Hardware Software 
Processor: i7-6000, 2.80 gigahertz OS: 64-bit Windows 10 
Primary Memory: 16 gigabytes RAM API: Keras [50] 
GPU: NVIDIA GeForce GTX 770 Backend: TensorFlow [51] 
Storage: Solid State, 250 gigabytes Language: Python 3.7.3 [52] 
 
This experiment evaluates the computation result using the parameters, such as accuracy, 
specificity, sensitivity, and F-score. These parameters are achieved using True Positive (TP), False 
Positive (FP), True Negative (TN), False Negative (FN) derived from the confusion matrix. 
Equation (5.1) to Equation (5.5) represents the computing formula of these five performance 
parameters from the value of confusion metrics. 
                              𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 (𝐴𝐶𝐶) =
𝑇𝑃+𝑇𝑁
𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁
                               (5.1) 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 (𝑆𝑃) =
𝑇𝑁
𝑇𝑁+𝐹𝑃
       (5.2) 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑆𝐸) =
𝑇𝑃
𝑇𝑃+𝐹𝑁
       (5.3) 
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𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 (𝑃𝑅) =
𝑇𝑃
𝑇𝑃+𝐹𝑃
        (5.4) 
𝐹 − 𝑠𝑐𝑜𝑟𝑒 (𝐹𝑠) = 2 ×
𝑆𝐸×𝑃𝑅
𝑆𝐸+𝑃𝑅
       (5.5) 
The accuracy comparison of the model for lesion detection and segmentation of different 
medical image datasets is mentioned in Table 5.2, 5.3, and 5.4 with other measurement technique 
such as precision recall, and F1-score. The accuracy of the model was compared with other state-
of-the-art method and showed significant outcome. 
5.5.1   Retina Blood Vessel Segmentation Results 
Retinal blood vessel segmentation based on DRIVE dataset is considered here with the 
proposed segmentation technique using deformable cascaded W-net architecture. Figure 5.3 
depicts the segmentation output of DRIVE dataset using three different columns. The retinal blood 
vessel input images represented in first column, the second column represented the ground truth, 
and the third column demonstrated the segmented image. It has been observed that the deformable 
cascaded W-net showed significant segmentation outcomes. 
 
 
   (a) Image            (b) Ground Truth     (c) Segmented Image 
           Figure 5.3   Segmentation Output of DRIVE Dataset 
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The proposed deformable cascaded W-net segmentation model’s performances have been 
compared with state-of-the-art segmentation techniques. It has observed in Table 5.2 that the 
model showed significant accuracy results with sensitivity, specificity, Recall, and AUC by 
comparing with other segmentation model. The proposed deformable cascaded W-net model 
provides a testing accuracy 95.68 with a AUC of 0.97. 
 
Table 5.2 Blood Vessel Segmentation Model Comparison 
Model Accuracy Sensitivity Recall F1-Score AUC 
Chen [35] 94.74 0.72 0.97 - 0.96 
Liskowsk [36] 94.95 0.77 0.97 - 0.97 
U-net [37] 95.31 0.75 0.98 0.81 0.97 
Proposed Model 95.68 0.77 0.98 0.82 0.97 
 
5.5.2   Skin Cancer Lesion Segmentation Results 
Skin cancer lesion segmentation based on Kaggle dataset is considered here with the 
proposed segmentation technique using deformable cascaded W-net architecture. Figure 5.4 
depicts the segmentation output of the Kaggle dataset using three different columns. The skin 
cancer input images represented in first column, the second column represented the ground truth, 
and the third column demonstrated the segmented image. It has been observed that the deformable 
cascaded W-net showed significant segmentation outcomes. 
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   (a) Image            (b) Ground Truth    (c) Segmented Image 
           Figure 5.4   Segmentation Output of Skin Cancer Dataset 
The proposed deformable cascaded W-net segmentation model’s performances have been 
compared with state-of-the-art segmentation techniques. It has observed in Table 5.3 that the 
model showed significant accuracy results with sensitivity, specificity, and Recall by comparing 
with other segmentation model. The proposed deformable cascaded W-net model provides a 
testing accuracy 99.24 with a F1-score of 0.98. 
Table 5.3 Skin Cancer Segmentation Model Comparison 
Model Accuracy Sensitivity Recall F1-Score 
TDLS [45] 98.30 0.91 0.99 - 
U-net [46] 93.14 0.95 0.93 0.86 
Jafari [47] 98.50 0.95 0.98 - 
Proposed Model 99.24 0.98 0.99 0.98 
 
5.5.3   Lung Segmentation Results 
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Lung segmentation based on Kaggle Data Science Bowl 2017 dataset is considered here 
with the proposed segmentation technique using deformable cascaded W-net architecture. Figure 
5.5 depicts the segmentation output of Kaggle dataset using three different columns. The lung 
input images represented in first column, the second column represented the ground truth, and the 
third column demonstrated the segmented image. It has been observed that the deformable 
cascaded W-net showed significant segmentation outcomes. 
 
   (a) Image              (b) Ground Truth    (c) Segmented Image 
           Figure 5.5   Segmentation Output of Lung Dataset 
The proposed deformable cascaded W-net segmentation model’s performances have been 
compared with state-of-the-art segmentation techniques. It has observed in Table 5.4 that the 
model showed significant accuracy results with sensitivity, specificity, Recall, and AUC by 
comparing with other segmentation model. The proposed deformable cascaded W-net model 
provides a testing accuracy 98.76 with F1-Score of 0.98. 
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Table 5.4 Lung Segmentation Model Comparison 
Model Accuracy Sensitivity Recall F1-Score 
U-net [48] 98.28 0.93 0.98 0.96 
Hieu [49] 93.00 - - 0.87 
Proposed Model 98.76 0.98 0.99 0.98 
 
 Summary 
We proposed an extension of the U-Net architecture using deformable cascaded W-net. 
The deformable convolutional network with cascaded W-net architecture is considered to form 
architecture of the model. These models were evaluated using three different applications in the 
field of medical imaging including retina blood vessel segmentation, skin cancer lesion 
segmentation, and lung segmentation. The experimental results showed that these proposed models 
ensure better performance with the testing phase by comparing with the state-of-the-art methods.  
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6 ENSEMBLE METHOD FOR PREDICTION OF CANCER METASTASIS USING 
MICROARRY GENE EXPRESSION DATA THROUGH MACHINE LEARNING 
 Introduction 
Cancer causes highest number of deaths in the world now-a-days. It has been identified in 
many analysis that 13% of overall deaths caused by cancer. Cancer study has attained a significant 
success over last couple of years as scientists are currently concentrating on detection of cancer 
based on image, signals, and gene expression dataset. Moreover, automated identification and 
diagnosis can ensure better treatment for the patient as it reduce the processing time of cancer 
identification. The microarray technology has been a key interest of scientist and practitioner in 
bioinformatics related area [54]. The assessment and prediction of microarray data have immense 
influence in medical disease diagnosis last couple of decades as the microarray contain 
biomolecular evidence from tissue and cell samples correlated to various categories of cancer. 
Moreover, the microarray contains expressions of thousands of genes that helps to distinguish 
different tumor types based on revealing the patterns of normal and diseased cell genes.  
The genomic scale pattern permits the scientist to supervise the genes with a view to 
classify and diagnosis cancer. To predict and classify cancer from gene expression dataset, the 
statistical and machine learning methodologies are crucial to effectively identify cancer outcome.  
Automatic identification and diagnosis using machine learning algorithms makes the 
classification, prediction, detection, and segmentation task easier and that helps to get desired 
output. Moreover, a precise and efficient disease estimation can decrease the threat of the cancer 
and increase the chances to get healed. Practitioners can rely on the dataset to take necessary action 
as the models can effectively identify the cancer.  
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Figure 6.1   Metastasis Spreads from Organs to Lymph Nodes [55] 
 
The transmission of metastasis from tissue to lymph nodes has demonstrated vividly in 
Figure 6.1 to detect tumor using genes and metastasis phases. To ensure better accuracy results 
from gene expression dataset, it is mandatory to analyze all the genes in terms of identify cancer. 
However, the large number of features in cancer gene expression dataset make the task challenging 
to consider most of the genes as the dataset is imbalanced with higher dimensional. To overcome 
the high dimensionality of the dataset data mining and machine learning method would be a good 
choice. Moreover, feature selection and feature extraction technique become the blessing for the 
practitioner to effectively identify cancer from the reduce number of genes. Several feature 
selection and feature extraction technique has been proposed in different literature for microarray 
gene expression data analysis. 
The reduced feature can be considered to identify cancer based on machine learning 
algorithm and that surely decrease the processing time for doctors to identify cancer biomarkers. 
However, feature reduction is not an easy task and the research shown that none of the feature 
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selection and feature extraction technique is sufficient for microarray dataset to identify cancer. 
Moreover, considering a limited number of dimensionality reduction approach could not represent 
the dataset appropriately. Therefore, all the feature selection and feature extraction technique need 
to be applied on benchmark dataset to identify cancer with better accuracy results.   
In this research, we focused on colorectal cancer and breast cancer microarray dataset that 
consists of huge number of gene features. The microarray dataset is normalized by considering a 
range of value before fed into the machine learning model. Numerous machine learning techniques 
like logistic regression (LR), support vector machines (SVM), perceptron, gaussian naïve bias, k-
nearest neighbor (KNN), random forest (RF), and artificial neural network (ANN) models are 
considered to detect and predict cancer from the colorectal and breast microarray dataset. The 
dataset split into training and testing phase with different set like (70-30) %, (60-40) %, and (80-
20) % with 10-fold cross validation process and finally fed into the machine learning model to get 
accuracy results [56].  
The major objective of this investigation is to detect the substantial features from the gene 
expression dataset to discover the baseline classifier with better accuracy result in terms of 
identifying cancer. The classifiers are compared with the prediction rate as well as other metrics 
such as F1 score, precision, and recall. The essential breakthroughs of this effort remain as follows: 
 Numerous machine learning techniques like logistic regression (LR), support vector 
machines (SVM), perceptron, gaussian naïve bias, k-nearest neighbor (KNN), random 
forest (RF), and artificial neural network (ANN) models are considered in a Python Jupyter 
Notebook environment.  
  Several feature extraction techniques like Principal Component Analysis (PCA), Linear 
Discriminant Analysis (LDA), t-distributed Stochastic Neighbor Embedding (t-SNE), 
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Independent Component Analysis (ICA), and Multidimensional Scaling (MDS) are applied 
both for colorectal cancer and breast cancer microarray dataset to reduce number of 
features. The classification accuracy is compared with and without feature extraction 
technique and the reduced features showed significant performances. 
 A few feature selection techniques like Recursive Feature Elimination (RFE), Randomized 
Logistic Regression (RLR), Gradient Boosting Machines (GBM), Adaboost (Ada), Deep 
Neural Network (DNN), Minimum Redundancy Maximum Relevance (mRMR), 
Correlation Feature Selection (CFS), Hilbert-Schmidt Independence Criterion Lasso 
(HSIC-Lasso), and Relief-F applied both for colorectal cancer and breast cancer microarray 
dataset to select significant features. The classification accuracy of different machine 
learning model is compared with and without feature selection technique and the subset of 
features showed significant performances. 
 Clustering techniques like K-means, Expectation Maximization (EM), Farthest Fast (FF), 
and Density Based (DB) clustering are applied for both the colorectal and breast cancer 
microarray dataset and compared the accuracy results.  
 Ensemble machine learning method is applied and compared the performance with the 
individual machine learning model. It has been observed that ensemble classification 
method showed better performances.  
The remainder of the chapter is organized as follows. In Section 5.2, the problem statement 
regarding this research has been considered. Section 5.3 investigated the microarray dataset used 
in this cancer classification and prediction. Section 5.3 describes about the methodology used for 
cancer detection and feature elimination with two microarray datasets. The comparison of different 
machine learning algorithm with and without feature selection and feature extraction technique is 
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performed in section 5.4. Moreover, the accuracy, precision, and recall are measured. Section 5.5 
concludes the paper with a few lines of future work.    
 Problem Statement 
Cancer has spreading at an alarming rate recent day and occurring different parts of the 
body like brain, breast, lung, skin, etc. In each year more than 1 million women have breast 
biopsies in the United State, and over a few thousands experience colorectal cancer.  Manual 
identification of cancer from image, genes, and histology images takes huge time to process the 
dataset. Automated detection of cancer from microarray gene expression dataset can reduce the 
processing time as well as give better detection rate.   
However, classification of microarray dataset from huge gene expression can experience 
certain issues, like a) less number of samples exist for microarray gene expression data, b) huge 
number of features observed for particular sample and some of the features are totally irrelevant, 
therefore, feature selection and feature extraction technique needed to reduce the number of 
features, c) due to investigational difficulty there might be noise in the dataset, d) efficient 
classification and feature extraction technique needed as the dataset is computationally complex.  
Several statistical and machine learning algorithms has been considered in recent study, 
but the accuracy and efficiency of the model is quite unsatisfactory. Moreover, feature selection 
and feature extraction technique needed to reduce the gene set with a view to get better accuracy 
results. Deficiency of contrast among the machine learning, feature extraction, and feature 
selection techniques to discover an improved framework for classification, clustering, and 
evaluation of microarray gene expression. Thus, dimensionality reduction of genes as well as 
feature selection approaches are crucial to enhance the accuracy and velocity of prognostication 
methods.  
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 Methodology 
In this section, a synopsis of applied classification algorithms is presented for microarray 
gene expression dataset for classification of cancer with and without feature selection techniques. 
6.3.1    Dataset 
Microarray is employed to characterize the representation of genes by utilizing numerous 
microscopic assessments to discover gene expression founded on light position in a sequence. In 
this study, two microarray cancer datasets are used, i.e. colorectal cancer and breast cancer dataset. 
The dataset is taken from an online Geo repository named NCBI Gene Expression Omnibus 
repository.  Colorectal cancer dataset consists of 120 different patient information based on 
metastasis and non-metastasis classes with 16385 gene expression. Moreover, breast cancer dataset 
consists of 97 different patient information based on metastasis and non-metastasis classes with 
24481 gene expression 
In pre-processing stage, the microarray gene expression datasets need to be normalized by 
considering a range in between 0 to 10 for all the gene expression features. To efficiently process 
the dataset, the normalized data need to be transposed rather than fed into the machine learning 
algorithm. The datasets accumulated values in numerical way, organized by rows and columns. 
The patient number represented in a column and the gene numbers represented in a row. Table 6.1 
lists the description of datasets, used in this paper, in terms of gene number, patient number, as 
well as the reference. 
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Figure 6.2   Microarray Data Processing [57]. 
 
In Figure 6.2, it has been observed that the microarray data collection process with several 
stages from the sample collection to microarray dataset generation along with normalization and 
pre-processing.  
Table 6.1   Microarray Colorectal Cancer Dataset with 16385 Features and Limited Samples 
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In Table 6.1, the colorectal cancer dataset used in the research has been represented for 120 
sample patients with 16385 gene expression features. Table 6.2 represented the two datasets used 
in this research with number of instances, total number of genes, and the classes for prediction.  
Table 6.2   Microarray Dataset with Instances and Classes 
Dataset Total Genes Instances Classes 
Colorectal Cancer 16384 120 2 
Breast Cancer 24481 97 2 
 
6.3.2    Proposed Method 
In this study, we introduce two frameworks for microarray gene expression data 
classification. Microarray datasets with huge number of genes need to be reduced to get the better 
accuracy results as there are several irrelevant genes are in a microarray dataset. Feature selection 
and dimensionality reduction techniques are overly used for reducing feature. The block diagram 
in Figure 6.3 represented the dimensionality reduction techniques for feature extraction from the 
gene expression data with a view to identify the significant genes for cancer classification.  
 
Figure 6.3   Block Diagram of Cancer Classification with Dimensionality Reduction. 
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The diagram applied for the classification of colorectal and breast cancer dataset with all 
the features based on popular machine learning algorithm like SVM, KNN, RF, ANN, and 
perceptron. The same algorithms are applied after reducing the number of genes by applying PCA, 
LDA, t-SNE, and MDS, etc [58]. The block diagram in Figure 6.4 represented the feature selection 
techniques to reduce features from the gene expression data with a view to identify the significant 
genes for cancer classification.  
 
Figure 6.4   Block Diagram of Cancer Classification with Feature Selection 
 
The diagram applied for the classification of colorectal and breast cancer dataset with all 
the features based on popular machine learning algorithm like SVM, KNN, RF, ANN, and 
perceptron. The same algorithms are applied after reducing the number of genes by applying RFE, 
RLR, CFS, mRMR, Relief-F, etc. 
5.4     Experimental Results 
The gene expression dataset employed in this study both for colorectal and breast cancer 
is split into training and testing set along with class labels like metastasis and non-metastasis and 
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gene expression features. The dataset split here in several ways, we initially considered 70% of 
the dataset as training and the 30% of the dataset as testing set. Secondly, 60% of the dataset as 
training set and the 40% of the dataset as testing set. Finally, 50% of the dataset is considered as 
training set and the 50% of the dataset as testing set. The confusion matrix for the actual and 
predicted results with positive and negative ratio with all the parts has shown in Table 6.3. 
Table 6.3 Confusion Matrix 
 
Accuracy, precision, recall and F-1 score are calculated by using the formula mentioned 
below based on true positive, false positive ratio in order to evaluate the overall predicted results.  
                           𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 (𝐴𝐶𝐶) =
𝑇𝑃+𝑇𝑁
𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁
                                  (6.1) 
         𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 (𝑆𝑃) =
𝑇𝑁
𝑇𝑁+𝐹𝑃
       (6.2)  
         𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑆𝐸) =
𝑇𝑃
𝑇𝑃+𝐹𝑁
       (6.3) 
                         𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 (𝑃𝑅) =
𝑇𝑃
𝑇𝑃+𝐹𝑃
                      (6.4) 
         𝐹 − 𝑠𝑐𝑜𝑟𝑒 (𝐹𝑠) = 2 ×
𝑆𝐸×𝑃𝑅
𝑆𝐸+𝑃𝑅
       (6.5) 
Several classification techniques applied for predicting colorectal and breast cancer from 
all the 16385 and 24481 features with 120 and 97 samples for detecting metastasis. Machine 
learning models such as LR, SVM, naive bias, KNN, RF, etc. are applied for both dataset with all 
features. Moreover, 10-fold cross validation approach is considered in a rotational way to classify 
cancer. All the classifier results are compared along with prediction rate and several metrics such 
as F1 score, precision, recall is computed to identify the baseline classifier.  
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In Table 6.4, the accuracy comparison of the machine learning models is represented with 
other metrics. From table 5.3, SVM showed accuracy result of 77.9% that is better than other 
classification models. LR and KNN showed next better accuracy results of 74.9% and 73.4% 
respectively. The precision, recall, F1-score for all the machine learning models observed in the 
following table.   
Table 6.4   Machine Learning Models with Dimensionality Reduction for Colorectal Cancer 
Machine Learning Avg. Test 
Accuracy 
Precision Recall F-1 
Score 
SVM 77.90 0.77 1.0 0.85 
SVM Reduced Features (80) 76.23 0.76 1.0 0.87 
LR 74.64 0.75 0.75 0.75 
LR Reduced Features (80) 56.50 0.56 0.56 0.56 
KNN 73.40 0.73 1.0 0.84 
KNN Reduced Features (80) 71.87 0.72 1.0 0.84 
Perceptron 76.45 0.74 1.0 0.85 
Perceptron Reduced Features (80) 54.10 0.54 0.54 0.54 
RF 68.40 0.71 0.71 0.71 
RF Reduced Features (80) 75.10 0.8 0.8 0.8 
Gaussian Naïve Bias (GNB) 73.59 0.68 0.68 0.68 
GNB Reduced Features (80) 72.35 0.65 0.65 0.65 
 
The block diagram mentioned in Figure 6.3 is considered machine learning technique with 
all the feature and the reduced number of features. For colorectal cancer 16385 is considered to 
evaluate the predicted results of the classifier applied for comparison. The same machine learning 
techniques applied after reducing the number of genes to 80 with dimensionality reduction 
technique and the identified gene sets are the most significant genes for colorectal cancer dataset. 
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The pictorial diagram of all the machine learning models comparison with accuracy measurement 
for colorectal cancer is mentioned in Figure 6.5.   
 
Figure 6.5   Colorectal Cancer Accuracy Comparison 
 
Dimensionality reduction convert the gene set to small number that can improve 
classification result to identify cancer efficiently and perfectly with less managing time. 
Classification model’s accuracy is cross checked with and without features.  
 
Figure 6.6   PCA to Reduce the Number of Dimensions Colorectal Cancer 
 
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
C
LA
SS
IF
IE
D
 IN
ST
A
N
C
ES
 (
%
)
CLASSIFIER MODEL
Classifier Accuracy
74 
In PCA the number of features reduced from 16385 to 80 and the accuracy, precision, recall 
and F-1 score of all the models with reduced features is closely related to the models with all the 
features. The PCA plot for colorectal cancer is mentioned in Figure 6.6. In ICA, the number of 
features reduced to 12 from 16385 depicted in Figure 5.7. Therefore, 12 genes are the significant 
genes for cancer occurrence. Moreover, t-SNE, factor analysis, and MDS is applied to reduce the 
number of features depicted in Figure 5.8, 5.9, and 5.10, respectively.  
 
Figure 6.7   ICA to Reduce the Number of Dimensions Colorectal Cancer 
 
Figure 6.8   t-SNE to Reduce the Number of Dimensions Colorectal Cancer 
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Figure 6.9   Factor Analysis to Reduce the Number of Dimensions Colorectal Cancer 
 
Figure 6.10   MDS to Reduce the Number of Dimensions Colorectal Cancer 
 
In Table 6.5, the accuracy comparison of the machine learning models for breast cancer 
classification is represented with other metrics. RF showed accuracy result of 72.3% that is better 
than other classification models [59]. The precision, recall, F1-score for all the machine learning 
models observed in the following table.  The block diagram mentioned in Figure 6.5 is considered 
machine learning technique with all the feature and the reduced number of features. For breast 
76 
cancer 24811 is considered to evaluate the predicted results of the classifier applied for 
comparison. 
Table 6.5   Machine Learning Models with Dimensionality Reduction for Breast Cancer 
Machine Learning Avg. Test 
Accuracy 
Precision Recall F-1 
Score 
SVM 63.7 0.62 0.90 0.79 
SVM Reduced Features (115) 61.2 0.59 0.85 0.81 
LR 64.5 0.68 0.74 0.71 
LR Reduced Features (115) 59.1 0.59 0.65 0.61 
KNN 58.4 0.63 0.79 0.69 
KNN Reduced Features (115) 55.8 0.59 0.77 0.64 
Perceptron 67.7 0.67 0.85 0.75 
Perceptron Reduced Features (115) 64.1 0.62 0.70 0.62 
RF 72.3 0.75 0.95 0.85 
RF Reduced Features (115) 69.9 0.80 0.98 0.80 
Gaussian Naïve Bias (GNB) 63.8 0.65 0.70 0.65 
GNB Reduced Features (115) 61.6 0.63 0.69 0.63 
 
 
Figure 6.11   Breast Cancer Accuracy Comparison 
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The same machine learning techniques applied after reducing the number of genes to 120 
with dimensionality reduction technique and the identified gene sets are the most significant genes 
for colorectal cancer dataset. The pictorial diagram of all the machine learning models comparison 
with accuracy measurement for colorectal cancer is mentioned in Figure 6.11.   
In Table 6.6, the feature selection approach like RFE, Relied-F, mRMR, DNN, and CFS is 
considered both for colorectal and breast cancer. The number of genes for both cancer dataset is 
reduced using the feature selection approach. 
Table 6.6   Number of Selected Genes using Feature Selection 
Dataset Total 
Genes 
RFE Relief-F mRMR DNN CFS 
Colorectal 
Cancer 
16384 95 110 850 700 110 
Breast Cancer 24481 120 131 1224 1000 130 
 
Table 6.7   Machine Learning Models with Feature Selection for Colorectal Cancer 
Method SVM KNN DT LR RF Ada GBM 
All Features 77.70 73.40 61.52 74.64 68.40 78.29 75.74 
RFE 95.23 87.44 79.65 96.17 92.73 90.87 81.48 
DNN 94.72 86.31 77.65 93.96 89.48 85.51 77.83 
RLR 96.59 83.90 74.71 91.84 88.14 87..07 75.40 
mRMR 92.30 81.26 73.35 87.44 87.12 86.46 76.21 
HSIC-LASSO 88.08 75.23 69.78 89.43 84.47 89.14 78.05 
Relief-F 94.91 79.62 77.32 93.19 92.42 93.59 80.43 
CFS 93.43 85.65 74.48 92.95 87.47 88.67 80.78 
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In Table 6.7, the accuracy comparison of the machine learning models like SVM, KNN, 
DT, LR, Ada, etc. is represented for colorectal cancer and RLR with SVM showed accuracy result 
of 96.59% that is better than other classification models. RFE with LR showed next better accuracy 
results of 96.17%.  Figure 6.12 showed the accuracy results of the machine leaning techniques 
with several feature selection method. 
 
Figure 6.12   Feature Selection Method Accuracy Comparison for Colorectal Cancer 
 
MLP with different number of layers and neurons for colorectal cancer is considered in 
Table 6.8. It is observed that MLP with 30 layers showed accuracy result of 86.25% 
Table 6.8   MLP with Number of Layers for Colorectal Cancer 
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90.75% that is better than other classification models. RFE with LR showed next better accuracy 
results of 89.62%. Figure 6.13 showed the accuracy comparison of the machine leaning techniques 
with several feature selection method. 
Table 6.9   Machine Learning Models with Feature Selection for Breast Cancer 
Method SVM KNN DT LR RF Ada GBM 
All Features 63.70 58.40 61.59 64.50 72.30 70.05 63.94 
RFE 90.75 81.05 67.70 89.62 87.16 82.55 72.39 
DNN 88.67 80.33 72.52 89.35 85.24 79.71 70.53 
RLR 89.25 80.19 71.45 87.63 85.27 84..91 70.08 
mRMR 87.12 77.93 69.49 84.13 81.56 83.68 69.57 
HSIC-LASSO 86.46 72.57 65.25 85.43 80.12 85.29 73.28 
Relief-F 89.72 75.45 70.21 88.92 86.14 88.35 74.95 
CFS 87.69 79.38 69.94 89.54 85.31 85.26 75.27 
 
 
Figure 6.13 Feature Selection Method Accuracy Comparison for Breast Cancer 
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MLP with different number of layers and neurons for breast cancer is considered in Table 
6.10. It is observed that MLP with 15-30 neurons showed accuracy result of 73.98%. 
Table 6.10   MLP with Number of Layers for Breast Cancer 
 15 30 60 15-30 30-60 
MLP 67.23 75.35 60.97 73.38 71.62 
 
In Table 6.11, the accuracy comparison of the several machine learning clustering models 
is represented, and EM showed better results for colorectal cancer and FF showed better results 
for breast cancer.  
Table 6.3   Clustering Methods for all Genes with Accuracy Measurement 
Dataset K-means EM FF DB 
Colorectal Cancer 81.86 92.78 89.56 83.37 
Breast Cancer 72.13 79.52 87.35 76.45 
 
In Table 6.12, ensemble method is considered for both colorectal and breast cancer. It has 
been identified that AdaBoost when applying with other classification method showed 
significantly better results. From Table 6.12, AdaBoost-RF showed accuracy result of 98.72% and 
97.89% for colorectal and breast cancer, whereas individual AdaBoost got accuracy result of 
78.29% and 70.05% for colorectal and breast cancer.  Figure 6.14 showed the accuracy comparison 
of the several ensemble techniques. 
Table 6.4   Ensemble Method Accuracy Comparison 
Method Colorectal Breast 
AdaBoost 78.29 70.05 
AdaBoost-RF 98.72 97.89 
AdaBoost-SVM 96.67 95.35 
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Figure 6.134   Ensemble Method Accuracy Comparison 
 
In Table 6.13, the accuracy comparison of the proposed ensemble model for colorectal and 
breast cancer dataset with other state-of-the-art methods is represented. The proposed ensemble 
for colorectal cancer showed accuracy result of 98.72% that is better than other classification 
models. Moreover, breast cancer ensemble method showed accuracy result of 97.89 that is better 
than other state-of-the-art classification model.  
Table 6.5   Ensemble Method Accuracy Comparison with Other Models 
Methods Dataset Total Genes Instances Classes Accuracy 
(%) 
Turgut [60] Breast 24481 97 2 88.82 
Kavitha [61] Breast 47294 97 2 96.44 
Sergey [62] 
Colorectal 2000 62 2 93.75 
Breast 24481 97 2 86.09 
Abinash [63] 
Colorectal 2000 62 2 86.00 
Breast 24481 97 2 97.61 
Proposed Ensemble 
Colorectal 16384 120 2 98.72 
Breast 24481 97 2 97.89 
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6.5 Summary  
Statistical and machine learning models has fantastic influence in cancer detection from 
microarray gene expression dataset. The massive features in the dataset is normalized and 
employed to machine learning models to identify the baseline classifier for both colorectal and 
breast cancer. The raw dataset with all the gene features is considered and calculate the accuracy, 
precision, recall, etc. to predict cancer. The same dataset is used for the classification model with 
reduced number of features by applying feature extraction and feature selection techniques. The 
reduced features showed significant improvement in cancer identification with better accuracy 
results and less processing time.  Feature extraction techniques like PCA, LDA, t-SNE, MDS, etc. 
are applied to reduce the number of features. Moreover, feature selection techniques like RFE, 
RLR, mRMR, Relief-F, etc. are applied for selecting the reduced gene set.  Machine learning 
techniques like SVM, RF, DT, KNN, ANN are applied to identify the baseline classifier. Finally, 
an ensemble technique is applied to combine a few machine learning techniques and it has been 
observed that ensemble model showed better accuracy result. 
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7 INTEGRATIVE ANALYSIS OF HISTOLOGY, IMAGING, AND GENOMICS FOR 
CANCER BIOMARKER DETECTION  
 Introduction 
Understanding the biological behavior for cancer prognosis has been a crucial issue over 
the years. Cancer spreading in an alarming rate and manual identification process is not sufficient 
for disease diagnosis. Automated identification of cancer lesion has significant impact on the 
performances of disease prognosis and reduce the processing time of the doctors for cancer 
detection. Therefore, computer aided system has been performed using machine learning and deep 
learning models [64-67]. Deep learning model like convolutional neural network with other feature 
extraction technique has been used for microscopic image classification, radiology image 
segmentation and classification, and genome expression analysis for retrieving useful information 
for disease prognosis.  
As cancer occurred several parts of the body, an individual analysis of histology, imaging, 
or genomics is not enough to detect abnormality in the dataset for disease diagnosis. Moreover, 
individual analysis using machine learning and deep learning models with limited samples might 
not be beneficiary for identifying appropriate disease outcome as overfitting issue can arise [68]. 
An integrated analysis of histology, imaging, and genomics for cancer biomarker detection would 
be a great choice now-a-day. Moreover, histo-genomics analysis, radio-genomic analysis, and 
molecular-genomic analysis has been a key concern to ensure better diagnosis of the disease [69]. 
Multiple analysis based on multiple types of dataset can produce significant results for biomarker 
detection. Correlation analysis among radiology-image, histology-image, and genome sequence 
can generate better predictive results that might not be possible to achieve from an individual 
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analysis of image, histology, or genome data. Research also shows that combination approaches 
of any of the above also represent better performances than individual analysis. 
In this research, we focused on integrative approach for lung cancer analysis and detection 
as lung cancer is the prominent cause of cancer-related death. Recent lung cancer study 
experienced a new type of lung cancer named Non-small cell lung cancer (NSCLC) and around 
80% of the lung cancer patients are diagnosed with this type [70][71]. In NSCLC, computed 
tomography (CT) scan images are enormously used for disease diagnosis. The correlation of CT 
scan image features with microarray gene expression analysis of NSCLC has significant impact 
for cancer biomarker detection. Research showed that the combination approach of image modality 
and gene expression sets achieve better accuracy results rather than considering the individual 
approach of image or genome analysis [72]. The objective of this research is to evaluate the 
correlation between CT radiomics features and gene expression sets in NSCLC.  
This chapter is organized as follows: Section 7.2 describes the proposed method for lung 
cancer integrative approach. Section 7.3 describes the dataset. Section 7.4 presents the 
experimental results. Finally, the conclusion is drawn in Section 7.5. 
 Methodology 
We consider a radio-genomics association study in this research by incorporating the lung 
cancer CT image features with microarray gene expression data in NSCLC. The correlation of the 
two different analysis has been considered to achieve significant results in terms of disease 
diagnosis. The research carried out in two different steps for image and genome expression 
analysis. Firstly, correlation map was produced based on the feature extracted from CT scan image 
and microarray gene expression data in NSCLC. Secondly, evaluation of the model using 
mathematical and statistical procedure to detect biological findings in the NSCLC dataset. The 
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block diagram of proposed integrated framework for biomarker detection in terms of disease 
diagnosis has been depicted in Figure 7.1. The figure represented the association study of the radio-
genomics and histo-genomics analysis with a view to predict cancer biomarker that could support 
disease diagnosis and remedial treatment of the patients.  
 
 
Figure 7.1 Proposed Integrated Framework for Biomarker Detection 
The input CT scan images in NSCLC is going through a couple of steps like image 
augmentation, normalization, segmentation, feature extraction, etc. [73-76]. We deployed the CT 
images and applied the image pre-processing and analyzing the image in computer vision 
approach. Deep learning techniques like U-net, V-net, Y-net, W-net has shown significant 
outcome for cancer lesion detection. Moreover, Convolutional Neural Network (CNN) has great 
impact in segmentation purpose. We considered U-net architecture for separating the lung from 
other tissues in CT scan images. End-to-end and pixel-by-pixel processes are deployed to generate 
the lung patches with a view to separate lung [77]. Tumor area are detected, and nodule detection 
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has been performed for lung cancer detection. Figure 7.2 depicted the lung segmentation task from 
input image to segmented output in NSCLC. 
 
 
 
Figure 7.2 Non-Small Cell Lung Cancer Segmentation  
Features are extracted from the lung CT scan images. The features are of textural features, 
HOG (Histogram of Oriented Gradient) features, and wavelet features. Several filtering techniques 
applied on those features in terms of reducing the redundant features in NSCLC. The microarray 
gene expression dataset of NSCLC is normalized by considering a range of value before fed into 
the machine learning model. Dimensionality reduction procedure like PCA, LDA, t-SNE, 
multidimensional scaling etc. [78] is applied to reduce the number of genes in NSCLC. Numerous 
clustering technique like k-means, hierarchical clustering technique also applied to determine the 
number of clusters in gene expression set and it may lead to reduce the number of genes in NSCLC. 
We considered 180 cluster from the gene expression sets and made relationship among the clusters 
based on the metagenes. In this research, 130 useful metagenes is generated and we analyzed those 
87 
genes and compared with performance measurement techniques. Several gene specific tests like 
p-test and t-test is considered and allocate grades to each gene with a view to identify metagenes 
with CT scan radiomic features.  The association study of CT scan image feature on top of 
microarray gene expression analysis showed significant outcome for cancer detection in NSCLC.   
 Dataset 
The dataset used in this research contains CT scan images and microarray gene expression 
dataset for NSCLC. The publicly available dataset is collected from The Cancer Imaging Archive 
(TCIA) of 89 samples of NSCLC. More specifically, NSCLC dataset of radiomics and genomics 
collected from Gene Expression Omnibus (GEO). The publicly available dataset of GEO Series 
Accession Number is GSE58661. From the dataset, separate analysis has been performed for 
radiomics analysis and genomics analysis using traditional machine learning and deep learning 
models. Finally, a correlation of the two processes has been considered for better analysis of the 
datasets in terms of achieving significant results in disease diagnosis.  
 Experimental Results 
The proposed model is considered for integrative analysis of CT scan and microarray data 
for non-small cell lung cancer detection. Technically, Python programming language with Keras 
and TensorFlow is used for the classification purpose. The hardware and software system 
specification are mentioned in Table 7.1.  
Table 7.1 Hardware and Software Description 
Hardware Software 
Processor: i7-6000, 2.80 gigahertz OS: 64-bit Windows 10 
Primary Memory: 16 gigabytes RAM API: Keras [50] 
GPU: NVIDIA GeForce GTX 770 Backend: TensorFlow [51] 
Storage: Solid State, 250 gigabytes Language: Python 3.7.3 [52] 
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 We identified 90 textural features, 200 HOG features, and 700 wavelet features from the 
radiomics CT scan images of NSCLC. The microarray gene expression dataset consists of 60607 
number of genes that reduced to 180 most significant genes and finally identified 130 metagenes. 
The radiomic features are considered with the gene expression sets to form a correlation map based 
on statistical procedure and identified the pairwise significant feature from the NSCLC dataset. 
Table 7.2 describes the accuracy comparison of the metagenes based on CT scan feature and the 
microarray gene expression analysis. It has been identified from the table that metagenes 12 
showed significant result by comparing with other metagenes. Figure 7.3 depicted the 
representation of metagenes in a plot diagram.  
 
Table 7.2 Accuracy Comparison of the Metagenes based on CT Scan Features  
Methodology Accuracy 
Metagenes 12 90.12% 
Metagenes 18 87.66% 
Metagenes 25 89.32% 
Metagenes 32 81.68% 
Metagenes 53 82.52% 
Metagenes 71 78.56% 
Metagenes 79 86.95% 
Metagenes 84 85.65% 
Metagenes 97 77.74% 
Metagenes 105 86.81% 
Metagenes 119 82.23% 
 
89 
 
Figure 7.3 Plot Diagram of the Metagenes Performances 
 
7.5     Summary 
This research showed an association study of the CT scan images and microarray gene 
expression dataset of NSCLC. It has been found in many studies that the performance of 
combination approach in disease diagnosis exceeds the individual study of histology, imaging, or 
genomics. A radio-genomics analysis of NSCLC has been analyzed here. The image features are 
extracted from the CT scan images and microarray gene expression dataset is considered for 
identifying metagenes on top of the radiomic image. This research focused on radio-genomics 
approach, but histo-genomics, and molecular-genomics approach can be considered in terms of 
achieving better results in disease diagnosis that may eventually reduce the death rate of the patient. 
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8 INTERNET OF MEDICAL THINGS (IoMT) BASED BLOCKCHAIN 
FRAMEWORK FOR ELECTRONIC HEALTH RECORD MANAGEMENT  
The health care industry is one of the biggest industries in the market. 11.2% of the total 
gross domestic product (GDP) was spent on healthcare in Germany, which was third highest in the 
world. Only countries that spent more were the United States at 16.9%, followed by 12.2% by 
Switzerland in 2018 [78][79]. 35.24% of the total population in Germany is overweight and 
21.29% are obese, the population worldwide is aging, and physician and nursing shortages are 
anticipated [80]. Hospitals are still spending a sizable amount of resources into processing medical 
claims and administrative records [81].  
Our world is becoming more interconnected and data-driven and so is healthcare. On the 
other hand, these changes are coming with the cost of high regulation, overhead cost and extra 
educational requirements for those who participate [81]. Therefore, changes in healthcare are 
slower. By 2030, the way healthcare is delivered is expected to change drastically due to increased 
access to data, additive manufacturing AI, and the wearable and implanted devices to monitor our 
health [82]. The evolution of e-health application and its ability to improve healthcare practices by 
electronic processes has had a positive influence on the healthcare sector [83]. 
The range of body functions that can be tracked using wearable in growing. Body functions 
such as blood pressure, hydration, oxygen level, brain activity (EEG), glucose, respiration, 
temperature, heart rate, and variability and movement can be tracked through the wearable 
technology available today [84]. "From assistance for Alzheimer’s patients to understanding 
complex knee injuries, wearable computing will transform how we understand pharmaceuticals, 
rehabilitation and preventative care.” [85]. The health-related wearables devices for monitoring 
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and managing the health and well-being of individuals outside the medical institutions are growing 
to support healthcare [86]. 
 
Figure 8.1   Blockchain Information system types [83] 
 
Health-related IoT promises many benefits and is already paving the way for better 
personalized diagnosis, with healthcare evolving towards a system of predictive, preventive, and 
precision care [87]. This technology also enables real-time monitoring of patients, fitness and well-
being monitoring, medication dispensation and data collection for research in the field of 
healthcare. 
The primary goal of the thesis is to establish a decentralized access control system, which 
provides the opportunity to share digital resources and transfer defined access rights from one 
organization to another organization without having a central authority across organizational 
boundaries. In order to be able to answer this broad question, the following issues must be 
addressed:  
 How to create a decentralized access control system?  
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In a decentralized and collaborative environment, centralized access control 
systems are not a suitable solution, so developing decentralized access control mechanism 
is crucial for decentralized systems.  
 How can organizations grant or transfer access rights of micro services from one 
organization to another?  
Traditional access control systems are mostly centralized, so there is a single place 
to store access permissions. When the access control systems are centralized, granting and 
transferring access rights becomes a challenge. With decentralized systems in a 
collaborative environment, access control systems need to grant access rights in a 
decentralized architecture. Also, transferring the access rights is an essential feature for a 
decentralized access control system.  
 How can consumer organization directly access the provider organization’s micro 
services?  
When the resource provider organization grants access rights for its own 
microservices, the challenge is how the consumer organization can directly access the 
microservices without having additional third-party services. 
 Background and Motivations 
The main objective of the blockchain research is to gain deeper understanding of the 
blockchain technology and its potential for healthcare systems. To come up with purposeful 
conclusion, a fundamental research question is formulated: 
“What is blockchain technology and how does it fit into current healthcare system?” To 
answer the main research question, and conduct the study in structured demeanor, the research 
question is broken down into several sub-questions:  
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 What is blockchain technology and what are its implications?  
 What are the application areas of blockchain?  
 What is the current state of healthcare systems? 
 What is current state of blockchain regarding healthcare industry? 
 Which fields within healthcare sector can make use of blockchain technology? What 
solution concerning blockchain technology can be implemented in the healthcare sector for 
secured sharing of medical contents? 
 What open issues exists and what are area for future research? 
 
Figure 8.2 Blocks in a Blockchain [85] 
 
This work is focused on the application of blockchain on a medical insurance storage 
system. In an ideal and basic medical insurance business, there are a group of hospitals, a patient 
and an insurance company. The insurance company can know a sum of the patient’s specified 
spending records however the company cannot learn the details of the spending records.  
The other hospitals can help the insurance company to process a patient’s spending records 
without learning anything about the records. Specifically, we propose a privacy-preserving system 
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which utilizes blockchain technology to store and process medical insurance data, which is 
characterized by the following features: 
• Our system is fully decentralized, as there is no trusted third party to provide 
authentication. 
• The data is verified and securely stored before being included in the blockchain, which 
provides high credibility to users. 
• We adopt the (2, 3) threshold secret sharing protocol among participating hospitals, so 
that the final data can only be obtained if at least 2 hospitals respond to the insurance company’s 
request. 
• Every data stored on the blockchain can be efficiently verified by anyone, and even 
though the encryption is secure, the verification requires very little computational power. Results 
are obtained with the use of efficient homomorphic computation. 
The remainder of the paper is organized as follows. The investigated problem is formalized 
in Section 8.2. Section 8.3 introduces challenges of blockchain. In Section 8.4, we investigate the 
working scenario of inference. The evaluation results are presented in Section 8.5. Section 8.6 
concludes the paper. 
 Problem Statement 
Healthcare is considered as one of the application areas of blockchain technology. But the 
technology adoption in the healthcare industry is relatively slow, and has been highlighted in the 
background paper on conceptual issues related to the health system, where the authors state that, 
“Pragmatic solutions already exist to address many of the greatest global health challenges, yet 
progress remains frustratingly slow because many health systems are constrained and cannot fully 
operationalize them.[56] Care coordination between patient and health care provider is increasing 
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in complexity as various chronic conditions in the aging and growing population continue to rise. 
In many scenarios, the technology available in health care is not sufficient to capture all forms of 
care being catered. This is mainly due to use of old age technology to transfer information between 
relevant parties. Health care providers still use legacy systems, and paper-based medical records 
to retrieve and share medical data. Health care providers are still investing ample amount of 
resources into processing medical claims and administrative records when most of this can be 
eradicated using technologies such as Blockchain. Also, when it comes to patient-doctor 
interaction in Germany, paper-based prescription is still persistent. When someone gets ill and 
visits the doctor, the prescription for medicine is given in a piece of paper. This paper needs to be 
taken to a chemist to receive the medicines. In case of the loss of the paper containing prescription, 
the patient must revisit the doctor. 
In this thesis, we try to find the impact blockchain technology can have in the domain of 
healthcare. On the other hand, we will also investigate the current state of blockchain technology 
and healthcare industry. We will then try to break healthcare into various subdomains (e.g. Health 
Information Exchange (HIE), claims adjudication and patient billing management, drug supply 
chain integrity, pharma clinical trials, etc.) and explore how each section can be improved through 
blockchain. 
 Challenges 
Protecting a person’s medical data privacy and ensuring that data integrity is a big 
challenge for any health care system when they are going to share the data through all over the 
world with different level of stakeholders for their system purpose. Right now, the standard of data 
has reached a good standard. Keeping electronic health record (EHR) in different workflows and 
creating a trusted environment as whole for taking different type of crucial decision for medical 
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fraternity is becoming important. It is important to ensure security of authority who is going to 
handle the system from up-to-date record of diagnoses, medication and services of individual 
person that is creating novel research area to improve total system [88]. It is going to be more 
important to update all the information for all stakeholder’s same time with secure protocol.   
For improving the total security of the EHR system is most valuable and crucial to give 
patients a healthy environment. In the country US, the health care system is looking for new secure 
and user-friendly environment [89]. Due to incentive system and federal laws have given access 
to health care data. It is also noticed that major hospital cannot share their safely. Patients’ needs 
new type of system, where they can share their information in secure way and hassle freeway for 
communication with different stockholder. Considering all these in mind a good solution should 
be required to give confront to user [90]. 
Thus, building an access control for cross-boundary organization is an important and 
challenging issue. For example, Organization A grants the access to Organization C to give access 
to its micro services, which are S1, S2, and S3. Then, if Organization C would like to transfer its 
access permissions to Organization B, the question is how organization A can grant access to 
Organization B based on transferred access rights. 
Figure 8.3. The primary blockchain structure adapted from [91]. The figure shows the way 
the ledger is structured in blockchain networks and describes the components that are inside the 
distributed ledger. The genesis block is assigned automatically when the network is started, with 
hash default values, and other blocks are inserted in the ledger following the genesis. In block 
structures, one could include components such as hash from the previous block, nonce, timestamp, 
block version, and the value known as the root of the Merkle tree. The Merkle tree is used to 
organize transactions into a blockchain network, and store them with security, as shown in the red 
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line. The attributes allocated into the block could be modified depending on the consensus protocol 
used; in summary, this figure presents the characteristics inserted in blockchain structure like 
Ethereum and Bitcoin implementations. 
 Methodology 
Electronic health record (EHR) is important to keep a person’s information as patient with 
confidential. IoMT is getting acknowledge from different stakeholders with Blockchain that gives 
secure path to continue the transaction between different actors. It possible to place the patient in 
secure way in health care ecosystem through Blockchain technology.   
Blockchain is composed of distributed system that keep records of different transactions. 
It keeps record in digital ledger of collective, unchanging record over time of peer to peer trades 
created from connected transaction blocks. It trusts on building cryptographic systems to give 
permission to each participant to share information between them even the peers have no pre-
existing trust certification. Creating platform for this new Blockchain based health system needs 
to establish few backbones before work with this in national wide. It is possible to reduce 
complexity using this system.  
Internet of medical things (IoMT) and blockchain is the key game player in near future. 
Using these two technologies there could be a huge change and revaluation is possible and what 
is already begin.  
Figure 8.3 represent a model that present a tentative diagram for including IoMT in the 
medical information system. In the figure, left part is the different devices those are consist of 
different sensors that collect health information and store in a local database, and it send data to 
central processing server for further evaluation of the medical information. Patient also have 
connection with central information processing center.  
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Figure 8.3   Proposed Model 
On the right side, the actors named health care support, laboratories support, government 
and insurance support are all connected with central information center. All these entities could be 
connected through blockchain system and make a secure way to transfer information to each other 
and keep track of the updates in same time to all the actors of the system. Blockchain is not a 
central system, it is a distributed platform to communicate with different actors in a system in 
secure way.  
Internet of Medical things is a platform with embedded system consist of different types 
of sensors that collect health information form a patient. Figure below is a block diagram of the 
IoMT with different types of sensors.  
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Figure 8.4   IoMT with embedded system with different sensors 
 
This figure 8.4, include fall detection sensor, blood pressure sensor, pulse sensor, body 
temperature sensor and all sensors are in cooperate with an embedded plat for that can 
communicate with other part to send information about a patient body condition. IoMT is new 
game changer in the field of agile medical health sector. 
The sequence diagram presents a full scenario for grant access to secure health care system 
is represented in figure 8.5.  There are 6 actors in the sequence diagram. Administrator has access 
to patient’s information. Patient’s has IoMT that has connection with web service application. Web 
service backend application has connection with blockchain. 
100 
 
Figure 8.5 Sequential diagram 
It sends information to blockchain and get notification from blockchain in different 
verification stage to secure the communication and update the total information. The system shares 
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public key to secure the shared information. Blockchain Nodes synchronize the information about 
the update of all actor’s information sharing and updating. In this way blockchain keep track of all 
the transaction between different stockholders of the system and keep the system secure through 
public key distribution. 
 Summary 
We explored the current situation of the healthcare sector and explored how blockchain 
technology can make the healthcare system more efficient and secure. We realized that any 
scenario that includes data exchange where multiple stake holders are involved can be a good use 
case for blockchain. Sharing health records, medical records and research data among multiple 
parties is a common thing in healthcare. Hence, we believe healthcare can be a good application 
area for blockchain. 
Firstly, we investigated the blockchain technology from a general perspective to 
understand how the technology works and investigated the different layers within blockchain. 
After having the basic understanding of blockchain technology and why it is gaining popularity, 
we investigated the different sectors where blockchain technology has had an impact or is starting 
or have an impact. For this, we discussed how different sectors can leverage blockchain and what 
solution already exists concerning blockchain.  
In addition, the healthcare industry was divided into small sub-sectors to study how each 
individual sector can leverage blockchain technology. For this, we briefly described how each 
sector can be made more productive through blockchain and provided some existing solutions. 
One of the most important and major parts of the thesis was to do a literature review where we 
investigated published scientific journal papers that discuss how blockchain technology can be 
implemented and incorporated with the healthcare sector. 
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9 CONCLUSION AND FUTURE WORK 
The majority of available classification and segmentation techniques for detecting cancer 
biomarkers, focus on cultivating, enhancing and conducting pragmatic investigations on diverse 
datasets which may not be suitable for advancing the state of the art. Instead, this dissertation 
examines classification and segmentation techniques from a distinct viewpoint. The main goal is 
to deliver a prognostication model that uses various biomedical images and microarray gene 
expression datasets to identify cancer biomarkers for disease diagnosis and provides predictions 
within reasonable accuracy. The model presented in this research showed significant contributions 
compared with state-of-the-art methods. Moreover, for the protection of biomedical datasets, 
blockchain technology is chosen for secured sharing of biomedical contents and genome 
expression data. This chapter provides an outline of our main approaches. 
 Synopsis of the Research  
The principal purpose of our research is to scrutinize and investigate classification and 
segmentation methods for cancer biomarker detection from multimodal images of different organs 
of the body such as lung, breast, and colorectal,  etc. to obtain insight to develop models that can 
improve performance in comparison to the state-of-the-art methods. The necessity of deeper 
knowledge of the classification, segmentation, and feature representation methods and identifying 
their characteristics is essential to improve the overall performance. This aided in building a strong 
classification and segmentation technique for better disease that can be used for more accurate 
diagnosis. Moreover, feature extraction and feature selection techniques are applied for microarray 
gene expression analysis for metastasis prediction. Dimensionality reduction techniques like PCA, 
ICA, LDA, and MDS are considered essential to reduce the number of genes in microarray datasets 
to get improve the overall accuracy with the selected significant genes. The literature review 
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conducted at the beginning of this research dissertation introduced background survey of 
biomedical image classification, segmentation, and genome expression analysis for disease 
diagnosis.  Moreover, we considered a blockchain technique in a distributed environment for 
secured sharing of medical contents among patients, doctor, and caregivers. The presented 
classification and segmentation techniques observed significant outcomes providing the efficacy 
of these methods. 
First, we offered a lung nodule detection and classification method for early diagnosis of 
lung cancer from publicly available lung images from LUNA, Kaggle, and LDIC-IDRI datasets. 
U-net with z-score normalization technique applied for pre-processing of the images with a view 
that focuses on white pixels for nodule identification. Moreover, an autoencoder with local binary 
pattern and flattening technique applied for lung nodule detection. Additionally, a 3D DenseNet 
classifier is applied for better detection of the nodule in lung CT images. The proposed model 
presented significant improvements for detecting nodule in lungs. We can apply the same approach 
for the 3D DenseNet model for multi organ disease classification to show the efficacy of the 
method. 
Second, we established an ensemble of pre-trained Convolutional Neural Network with 
transfer learning for microscopic image classification for detecting cancer types. Breast cancer 
histopathological image and cervical cancer microscopic images is considered with ensemble CNN 
model. Data augmentation and pre-processing techniques applied to augment the dataset before 
fed into the neural network. We have compared the model with other state-of-the-art methods and 
achieved significant performance for breast cancer detection and cervical cancer analysis. 
Third, we proposed an approach for colorectal cancer detection from GEO microarray gene 
expression data. Machine learning techniques have been applied to gene expression data and 
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compared the accuracy, precision, recall, etc. Finally, we reduced the number of genes by applying 
a several dimensionality reduction techniques and applied the same machine learning algorithms 
in order to compare the performances before and after the reduction of the genes. We were able to 
identify the most significant genes that are responsible for the colorectal cancer which represents 
a significant improvement. 
 Fourth, we offered a distributed environment secured with blockchain technique for the 
protection of sharing the medical contents among patients, doctors, insurance company, third 
party, and caregivers. A patient centric approach as well as electronic health record management 
technique applied to maintain the security while sharing, modifying the medical contents. 
Blockchain also applied for remote patient monitoring with internet of medical things for data 
collection and sharing through blockchain. A Hyperledger and an Ethereum technique is 
considered for building the blockchain architecture. 
To conclude, our results have been compared to the state-of-the-art methods and showed 
considerable improvement compared to well-known image classification and segmentation 
techniques used for disease diagnosis. Metastasis prediction also showed significant results in 
comparison with feature extraction and feature selection approaches. Further improvement can be 
possible by focusing on robust ensemble deep learning model for disease diagnosis.    
 Future Work 
In this dissertation, it has been observed that the proposed model for image and genome 
classification and segmentation showed significant accuracy improvement for detecting cancer 
biomarker. However, more accuracy improvement can be considered by focusing on robust deep 
learning models for cancer classification. In terms of microarray gene expression analysis, more 
feature extraction and selection technique can be considered for the benchmark dataset. Blockchain 
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has been used extensively in healthcare to secured sharing of medical content. But robust 
cryptographic algorithm can be considered for smooth and secure sharing of the data. 
There are several major concerns that should be addressed to contribute more in this 
research are stated below. 
 Analysis of the Proposed Classification and Segmentation Model for Disease 
Diagnosis  
In this analysis, following points are the key considerations for ensemble classification and 
segmentation method- 
1. More real-life datasets should be introduced to evaluate the model to overcome the 
overfitting issue.  
2. The ensemble classification method can be compared with other state-of-the-art ensemble 
method with multimodal multi-organ images. The running time of 3D DenseNet for 
volumetric image classification can be reduced by incorporating robust models.  
3. Data generation and augmentation using ensemble GAN can improve the accuracy of the 
model.  
4. Cost effective deep Bayesian Active Learning could be a good choice for biomedical image 
classification. More noble deep learning architecture can be proposed for cancer 
classification.  
 Association of Radio-Genomics, Histo-Genomics, and Biomolecular-genome analysis 
For performance evaluation of classification model using image, genome, and histology 
association study has the following key points- 
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1. In terms of disease diagnosis, imaging or genomics or microscopic study is not enough for 
finding better biomarker. Moreover, association study could be a good choice to ensure 
better accuracy results.  
2. Functional correlations among different association study of image-genome, histo-genome 
or biomolecular-genome can significantly improve the performances. Multiple way 
analysis of disease diagnosis would be reliable for disease diagnosis. 
3. Association study needs the dataset for the same sample size, and it is hard to manage the 
confidential biomedical dataset.  
 Blockchain Protocol in a Distributed System  
The following points are the main considerations for secured sharing of the biomedical 
contents based on blockchain- 
1. Analysis of the different protocol to generate the blockchain index and compare the 
performances of the protocol could be good idea 
2.  Ensemble graph algorithm can be considered for determining the architecture of the 
blockchain in a distributed system. Greedy graph algorithm can be applied for blockchain 
architecture.  
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